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Molecular farming is gaining traction as a cost-effective platform to produce recombinant 
proteins. Further improvements can be made, however, to increase overall yield especially 
for difficult to express proteins. In this study virus-derived silencing suppressors and 
replication elements were used with the aim of increasing expression and yield of enhanced 
green fluorescent protein (EGFP) and the Zika PrME polyprotein in Nicotiana benthamiana. 
A comparison of four viral silencing suppressor proteins was performed: these were tomato 
spotted wilt virus non-structural protein, NSs, tomato aspermy virus (TAV) 2b, tomato bushy 
stunt virus P19 and begomovirus alphasatellite Rep. Differences in EGFP expression in N. 
benthamiana due to the silencing suppression were determined using immunoblotting and 
fluorescence of EGFP. In addition, replication elements from three viruses (bean yellow dwarf 
virus [BeYDV], beak and feather disease virus [BFDV] and begomovirus alphasatellite) were 
assembled into novel plant expression vectors using GoldenBraid (GB) cloning technology and 
assessed using EGFP. Finally, the two approaches were combined in an attempt to express 
the Zika PrME polyprotein, which was assessed using immunoblotting. 
EGFP expression was found to be greatest in the presence of the TAV 2b protein and no 
difference in fluorescence intensity between the original BeYDV replicating plant expression 
vector and that constructed using GB could be detected; however, the GB assembly of the 
BFDV and alphasatellite plant expression vectors was unsuccessful. The TAV 2b combined 
with the BeYDV replicating elements were used for the expression of Zika PrME. The gene 
was successfully cloned into the replicating BeYDV vector and a vector that does not replicate 
(negative control). The PrME was not detected using anti-His tag immunoblotting despite 
optimisation for Agrobacterium infiltration density, harvest day post infiltration, signal 
peptides and buffers during extraction. 
In this study I demonstrated the following: that the TAV 2b protein out-performed all other 
silencing suppressors; that the GB cloning technology can be successfully applied in the 
development of novel plant expression vectors, although further optimisation is required for 
these and for Zika PrME expression. Further work in characterising the effect of silencing 
suppression on recombinant protein expression can be assessed using RT-qPCR to measure 
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the effect on mRNA levels. In summary, these improvements in plant recombinant protein 
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Chapter 1: Literature review  
Introduction  
The demand for pharmaceutical proteins has increased over the years due to emerging 
diseases. Vaccine production in turn is essential for preventing epidemics by providing 
protective immunity over long periods. It is important that vaccines are safe, easy to 
administer, cheap, stable and have minimum side effects  (Shanmugaraj & Ramalingam 2014). 
Pharmaceutical proteins have traditionally been heterologously expressed in mammalian, 
bacterial and insect cells (Rybicki, 2010). However, these bioreactors present multiple 
problems such as scalability, safety concerns and high cost. On the other hand, molecular 
farming, the production of recombinant proteins in plants or plant cell cultures is a successful 
platform for protein production (Rybicki, 2014). Plants are advantageous in that they do not 
support human pathogens and unlike bacteria, do not produce endotoxins. In addition, they 
are also capable of post-translationally modifying recombinant proteins and can easily be 
scaled up to agricultural levels. Recombinant proteins can be produced using transient 
expression systems or stable transgenic lines. Transgenic plants are considered a traditional 
approach to the production of recombinant proteins; however, the approach requires long 
generation times and results in only moderate protein yields  which contributes to the cost of 
downstream processing (Sabalza et al. 2014). Transient protein expression via agroinfiltration 
and viral based vectors is commonly used because higher expression can be achieved in less 
time and protein production can easily be scaled up since the transgene is not integrated into 
the genome to produce a transgenic plant (Daniell et al. 2009). 
A preferred method of biopharming is the use of virus-based transient expression via plant 
tissue infiltration. This approach makes use of a shuttle vector-based Agrobacterium 
tumefaciens tumour-inducing (Ti) plasmid. In nature Agrobacterium causes tumour formation 
in plant roots known as crown-gall disease. Subsequently, a binary vector was designed and 
DNA could be inserted between the right and left borders and used to transform plant cells 
(Krenek et al. 2015). Furthermore, tissue infiltration using A. tumefaciens ensures that the 
vector is delivered and released into the host tissue (Fischer et al. 2004; Regnard et al. 2010). 
Agroinfiltration is very versatile, as several recombinant Agrobacterium - each one harbouring 
a different vector with a different gene - can be used to infiltrate the same plant. All that is 
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required is that the vector maintains a stable copy number in the Agrobacterium. (Pushko et 
al. 2010). Nicotiana benthamiana, a tobacco relative, has been shown to be useful for 
agroinfiltration and expression of recombinant proteins due to its ability to support 
replication of various viruses (Goodin et al. 2008).  
The level of recombinant protein production is particularly important for commercial vaccine 
production. However, technical bottlenecks such as low yields and structural heterogeneity 
have hindered plant-based vaccine production. Protein yield depends on multiple factors such 
as genetic, epigenetic and biochemical environment. Manipulation of these different factors 
has been employed to increase protein yields in plants.  
Generation of viral vectors  
Virus-based vectors can be optimised for high protein expression or different plant host 
species. The viral genome is deconstructed or engineered in such a way that it eliminates non-
essential viral genes but maintains genes of interest which allows for replication and 
expression of the recombinant protein (Gleba et al. 2007). In addition, viral plasmids are 
designed based on the replication of the viruses themselves. Earlier vectors used in 
agroinfiltration were not as robust as the current plant virus-based vectors (Lico et al. 2008). 
Each virus is unique and therefore has its own disadvantages and advantages such as its ability 
to express small or large proteins. 
Vectors are categorised into first and second generation viral vectors. First generation vectors 
are capable of expressing all their genes including the gene of interest. This vector is 
essentially the wild-type virus that also allows for the expression of the recombinant protein 
under the control of a strong viral promoter. Plants can either be sprayed with the viral 
mixture or transfected with Agrobacterium as described by Azhakanandam et al., (2007), via 
‘agrospray’ or ‘wound and agrospray’. However, the researchers obtained a low yield of 0.04-
0.3 % total soluble protein (TSP) with this technique, which needs further improvements 
especially for industrial use. On the other hand, there has been successful expression of viral 
coat protein fusions of different genetic epitopes. In addition their immunogenicity and 
certain levels of protection has been demonstrated in animal models (Gleba et al. 2007; 
Azhakanandam et al. 2007).  
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The limitations experienced with first generation vectors lead scientists to engineer 
deconstructed vectors known as second generation vectors. These vectors were rebuilt using 
only the viral elements that were essential for expression of the gene of interest in a plant 
host system. The vector was completed using non-viral components that allow for infectivity, 
movement, replication or amplification and viral particle assembly. However, the lack of 
systemic movement and low protein expression levels were still a problem. Removal of the 
coat protein was introduced to reduce metabolic resources devoted to synthesis of a large 
coat protein and the use of Agrobacterium for systemic movements in plants (Gleba et al. 
2007). On the basis of these and many other findings a scalable protocol for protein 
expression and vector construction was designed. 
RNA virus expression systems  
RNA viruses were the first to be explored for use as viral vectors. Tobacco mosaic virus (TMV) 
is a single stranded (ss) RNA (+) virus that infects a wide range of plants especially tobacco. 
TMV is a rigid rod-shaped virus which belongs to the Tobusvirus genus and was the first virus 
investigated for viral vector development (Bos 1999). The well-known “deconstructed” 
MagnICON vector system from ICON Genetics relies on elements from TMV and turnip vein-
clearing virus (TVCV). Magnifection, the technique for transfecting these deconstructed 
vectors, has been used for the expression of antibodies, interferons, growth hormones, 
antigens, adjuvants and enzymes (Gleba et al. 2005). TMV was also used to generate the 
broadly neutralizing antibody (bnMAb) known as VRCO1 against HIV-1 in N. benthamiana 
plants. The TMV replicon vector was able to produce ≈ 150 mg of the bnMAb per kg of fresh 
leaf material 5-7 days post inoculation. These antibodies were biologically active in an HIV-1 
neutralization assay and their activity was demonstrated in a topically applied microbicide 
against HIV infection (Hamorsky et al. 2013). Furthermore, a TMV RNA-based overexpression 
(TRBO) vector was used to express the allergen R8 from dust mites in tobacco plants. The 
TRBO vector lacks the TMV coat protein gene and is characterized by its high protein 
expression levels, efficient agroinfection and its inability to form viral particles in the host. 
The plant-derived R8 antigen performed identically to the parent allergen. This was shown by 
the binding capacity of R8 and the parent allergen to IgE and the ELISA results that showed 
that R8 activated the TH1 and decreased the TH2 cell growth.  The R8 antigen could possibly 
be used as a candidate vaccine for allergen-specific immunotherapy of asthma (Li et al. 2013).  
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The cucumber mosaic virus (CMV) has a tripartite ssRNA genome and wide host range. Each 
genomic RNA is packaged in a separate icosahedral capsid which limits the size of any foreign 
transgene inserts (Hefferon, 2014b). A bipartite and tripartite CMV-based vector was 
designed to express GFP and Acidothermus cellulolyticus endo-1, 4-β-glucanase (E1) in N. 
benthamiana. The above CMV vector was based on a binary plasmid where the coat protein 
(CP) was replaced with a gene that encodes an α-1-antitrypsin [AAT]. Viral amplicons were 
induced upon the presence of an inducer (β-estradiol) which improved the efficiency of 
transgene expression. The researchers were able to show using GFP and E1 (a cellulose 
degrading enzyme) that the CMV-based vector was able to achieve transient recombinant 
protein expression at levels comparable to transgenic plants but with a reduced time and 
effort (Hwang et al. 2012). CMV particles have been successfully modified to display porcine 
circovirus type 2 (PCV-2) capsid protein epitopes on the surface of the particle (Gellért et al. 
2012). These plant-produced CMV:PCV2 particles were able to induce PCV specific antibody 
responses and showed protection against PCV in pigs.  
Cowpea mosaic virus (CPMV) has been extensively used as an expression system for the 
production of vaccines and other therapeutic proteins in plants. CPMV is an icosahedral, 
ssRNA (+) virus with a bipartite genome (Hefferon 2014b; Hefferon 2017). It was initially used 
for antigen presentation and was further developed by Medicago, Inc. (Durham, NC, USA) as 
a CPMV vector to generate virus like particle (VLP) carrying influenza virus HA antigens 
(Mardanova et al. 2017). The non-replicating expression vector, pEAQ, was also based on 
CPMV. The foreign gene is placed between the 5ʹ leader sequence and 3ʹ untranslated region 
(UTR) of RNA-2. A deletion of the in-frame initiation codon upstream of the main translation 
initiation site of RNA-2 contributed to a substantial increase in foreign protein expression 
(Sainsbury et al. 2009; Montague et al. 2011). These pEAQ vectors were used for the 
expression of anti-HIV antibodies and bluetongue virus-like particles (Thuenemann et al. 
2013; Sainsbury et al. 2010; van Zyl et al. 2017). CPMV non-infectious VLPs also known as 
nanoparticles have also been used in immunotherapy studies against cancer. The empty 
CPMV (eCPMV) nanoparticles were shown to reduce lung melanomas and induce an anti-
tumour response (Lizotte et al. 2016). In addition, they were able to demonstrate that the 
eCPMV nanoparticles cleared tumours in multiple anatomical locations such as the colon, 
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ovaries and breast. eCPMV was shown to be utilised as a direct cancer immunotherapy and 
not only as a drug delivery system to reduce tumours.  
Positive sense RNA viruses have been predominantly used for the construction of plant 
expression vectors and also sparked special interest as delivery vehicles for immunotherapy 
(Hefferon 2014; Hefferon 2017). However, researchers have become much more interested 
in DNA viruses such as the Geminivirus because of their significant expression levels. 
DNA virus expression systems 
Although ssRNA viruses are predominant among plant viruses, ssDNA plant viruses are 
becoming popular for use as vectors and in plant molecular biology. Viruses such as tomato 
yellow leaf curl virus (TYLCV), African cassava mosaic virus (ACMV) and bean yellow dwarf 
virus (BeYDV) belonging to the Geminiviridae family are common ssDNA plant viruses that 
have a particular impact on the economy (Scholthof et al. 2011). They are also suitable for 
vector development and have been successfully engineered for recombinant protein 
expression.  
Geminiviruses contain a small circular ssDNA genome ranging from 2.5–3.2 kb in length. The 
ambisense genome, monopartite and bipartite, is encapsidated in a twinned capsid. All 
geminiviruses contain a movement protein, a coat protein, a replication initiator protein (Rep) 
which is required for replication of the virus and an intergenic region, which holds a stem loop 
structure (Bisaro, 1996). These viruses replicate via rolling circle replication (RCR) with the 
help of the Rep protein which initiates replication at the stem-loop structures. Briefly, after 
the virus enters the nucleus the ssDNA is released which is then processed into a dsDNA 
intermediate by the host DNA polymerase. The Rep protein is then expressed and initiates 
RCR by nicking the dsDNA at a conserved nonanucleotide sequence located within the origin 
of replication (Bisaro, 1996; Hefferon, 2014a) 
Geminiviruses have been of particular interest to molecular biologists because of their ability 
to accumulate to very high copy numbers which results in high levels of gene expression. One 
of the early geminiviral-based replicon systems made use of ACMV, which has a bipartite 
genome demonstrating that geminiviruses can be deconstructed (Ward et al. 1988). The 
researchers replaced the capsid protein with a chloramphenicol acetyltransferase (CAT) gene 
which resulted in 80 U/mg of CAT levels. Other earlier vectors used to express reporter genes 
in plant cells included maize streak virus and wheat dwarf virus (Timmermans et al. 1992; 
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Matzeit et al. 1991; Palmer & Rybicki 2001; Shen & Hohn 1995). A replicon based on the 
BeYDV genome was designed specifically for recombinant protein expression by the deletion 
of viral genes and addition of a CaMV expression cassette. A 40-fold enhanced expression of 
the β-glucuronidase (GUS) reporter gene in tobacco plants was reported. The researchers also 
confirmed that the Rep protein can be supplied in trans on a separate vector (Mor et al. 2003). 
Based on this, it was reported that a 20-fold increase in Staphylococcus enterotoxin B protein 
(SEB) was expressed using a BeYDV-derived replicon (Hefferon & Fan 2004). However, there 
were some limitations which included the difficulty of regenerating replicating geminivirus 
genomes in transgenic plants and transient expression was limited to a number of sites per 
plant (Rybicki & Martin 2014; Palmer et al. 1999; Gutierrez et al. 2004). In 2006, a transgenic 
plant expression system was developed using BeYDV elements to express GFP and the 
Norwalk norovirus (NV) CP from doubly-transformed tobacco NT-1 cells and in transgenic 
potato plants. The Rep protein was under the control of an alcohol-inducible promoter and a 
high copy number of replicons was achieved when triggered with ethanol (Zhang & Mason 
2006). Furthermore, Huang et al. (2009) achieved maximum expression of hepatitis B core 
antigen (HBcAg) and NVCP after four days using a BeYDV replicon in leaves of N. benthamiana. 
To increase expression, the Rep/RepA was placed in trans and replication could be controlled 
by changing the strength of the promoter. The same group then constructed a single replicon 
system that contained the Rep/RepA genes in cis however, expression of HBcAg showed no 
substantial change when compared to the co-delivery of vectors. Regnard et al. (2010) 
designed a novel self-replicating expression shuttle vector, pRIC, based on a mild strain of the 
bean yellow dwarf virus (BeYDV-m) reported by Halley-Stott et al. (2007). The vector was 
designed to increase transgene expression through replicational increase in transgene copy 
number of the human papillomavirus type 16 (HPV-16) major CP and human 
immunodeficiency virus type 1 subtype C (HIV-1C) Pr55 Gag-derived p17/p24 antigen. In 
addition, the enhanced green fluorescence protein (EGFP) was used as a reporter in N. 
benthamiana. The vector differs from other BeYDV-derived vectors by the presence of a rep 
gene in cis rather than in trans. This allows the vector to replicate independently increasing 
the gene copy number and in turn increasing protein expression. The BeYDV CP and 
movement protein (MP) genes were replaced with an antigen-encoding transgene under the 
control of a CaMV 35S constitutive promoter. The researchers were able to achieve a 2-3 
orders of magnitude increase in amplicon copy number, 3-7 fold increase in HIV-1 and EGFP 
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protein expression and a 50 % increase for HPV-16 (Regnard et al. 2010). The Ebola 
glycoprotein (GP1) was also expressed using a geminiviral vector to produce an Ebola immune 
complex (EIC) which showed great potential as a plant-derived human vaccine (Seong et al. 
2011). Hepatitis A virus (HAV) VP1 and an Fc antibody fragment have also been expressed in 
N. benthamiana using a beet curly top virus (BCTV) replicating vector. Another example is the 
use of the dual-module in-plant activation (INPACT) expression platform based on the 
replication machinery of tobacco yellow dwarf mastrevirus (TYDV). INPACT cassette encoding 
the GUS reporter accumulated up to 10% TSP within 3 days after ethanol treatment. The 
INPACT cassette is uniquely arranged to allow for tight regulation of Rep. The gene of interest 
is split and can only be expressed when Rep is induced to form circular replicons (Dugdale et 
al. 2013).  
Although ssDNA viral vectors seem to be more advantageous than other viruses due to their 
wide host range, ability to replicate and vast amount of proteins produced during 
agroinfiltration, there is still room for improvement to increase recombinant protein 
expression. 
Silencing suppressor proteins to increase protein expression  
One of the advantages of plants is that they can easily be scaled up for industrial use. 
However, expression of recombinant proteins usually peaks three days after agroinfiltration 
and rapidly declines thereafter. Post-transcriptional gene silencing (PTGS) was the proposed 
reason for the rapid reduction in protein production (Voinnet et al. 2002; Johansen 2001). 
PTGS in plants involves the degradation of dsRNA, aberrant RNA and can also be triggered by 
replicating RNA and DNA viruses. During silencing these RNAs are processed by an RNase III 
type enzyme called Dicer into short, 21–24 nucleotide long, small interfering RNA (siRNA) 
duplexes. siRNAs activate the RNA-induced silencing complex (RISC) for target cleavage in a 
sequence-specific manner (Bernstein et al. 2001). The onset of PTGS triggers systemic 
silencing of the target RNA by sending silencing signals from one cell to another as well as to 
distant plant tissue (Olivier & Baulcombe 1997; Himber et al. 2003). Since viruses are inducers 
of RNA silencing in plants, viruses have had to evade or suppress RNA silencing. One-way 
viruses mitigate this defence is through the use of silencing suppressor proteins that can 
target different steps in the silencing pathway.  
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To date, many viral suppressor proteins have been identified including those from RNA and 
DNA viruses (Table 1). This group of proteins is diverse in sequence, functionality and 
evolutionary origin. This could be the reason that these silencing proteins target different 
steps of the silencing pathway (Palukaitis et al. 2008; Carrington et al. 2001). 
Table 1: Summary of identified silencing suppressor proteins (Csorba et al. 2015; Silhavy & Burgyán 2004) 
Family Virus Protein RNA/DNA 
Carmovirus Turnip crinkle virus P38 (+)ssRNA 
Cucumovirus 




Closterovirus Beet yellows virus P21 (+)ssRNA 
 Citrus tristeza virus P20, P23  
Comovirus Cowpea mosaic virus S protein (+)ssRNA 
Hordeivirus Barley yellow mosaic virus γb (+)ssRNA 
Pecluvirus Peanut clump virus P15 (+)ssRNA 
Polerovirus 
Beet western yellow virus, cucurbit aphid-
born yellow virus 
P0 
(+)ssRNA 
Potexvirus Potato virus X P25 (+)ssRNA 
Potyvirus 




Sobemovirus Rice yellow mottle virus P1 (+)ssRNA 
Tombusvirus 
Tomato bushy stunt, cymbidium ringspot 
virus; carnation Italian ringspot virus 
P19 
(+)ssRNA 
Tobamovirus Tobacco mosaic virus; tomato mosaic virus P30 (+)ssRNA 
Tymovirus Turnip yellow mosaic virus P69 (+)ssRNA 
Tospovirus NSs Tomato spotted wilt virus NSs (-)ssRNA 
Tenuivirus Rice hoja blanca virus NS3 (-)ssRNA 
Phytoreovirus Rice dwarf virus Pns10 dsRNA 
Geminivirus African cassava mosaic virus AC4, AC2 dsDNA 




Although literature about the suppressor proteins is quite limited, the first viral suppressor 
protein identified was from the Potyvirus family in 1998 (Anandalakshmi et al. 1998). The 
potyvirus-encoded helper component proteinase (HC-Pro) not only suppresses transgene- 
and virus-induced silencing but also maintains genome replication, long-distance movement 
through plants and polyprotein processing (Ma et al. 2009). Different models have been 
proposed for the function of HC-Pro, one being that HC-Pro supresses RISC activation by 
interacting with a protein/complex involved in siRNA unwinding (Chapman et al. 2004) 
Further studies clarified that HC-Pro impairs RNA silencing by inhibiting the assembly of RISC 
(Lakatos et al. 2006). 
The silencing suppression activity of cucumber mosaic virus (CMV) 2b protein was discovered 
in the same silencing reversal assay used for HC-Pro (Brigneti et al. 1998). In the expression 
study, GFP was only expressed in newly emerged tissue but not in older tissue where RNA 
silencing already took place before the viral infection. This suppression activity is similar to 
that observed from either TAV 2b (encoded by tomato aspermy cucumovirus) or p19 
(encoded by tomato bushy stunt tombusvirus). However, this is in contrast to that of HC-Pro 
and indicates that these proteins act at different stages of PTGS. Studies suggest that CMV 2b 
blocks silencing signals (Voinnet et al. 1998). Another study suggested that the localization 
signal and nuclear targeting signal encoded by CMV is also critical for the silencing activity of 
CMV 2b (Lucy et al. 2000) 
Voinnet et al. (2000) for the first time, showed that a viral protein prevented systemic 
signalling of RNA silencing. The systemic silencing activity of p25 protein of the potato virus X 
(PVX) was determined by co-infiltrating transgenic GFP N. benthamiana with 35S-p25 and a 
replicating PVX–GFP recombinant virus. P25 was able to suppress the silencing in the 
infiltration zone induced by 35S-GFP but not the PVX–GFP. This suggests that p25 inhibits the 
signal production or something upstream thereof since both local and systemic RNA 
transgene signalling is inhibited (Li & Ding 2001).  
Viral suppressor proteins regulate the complex defence arms race between plants and viral 
pathogens. Although studies on these proteins have been carried out for more than ten years, 
literature still lacks certain aspects of the molecular nature of viral suppressor proteins 
(Csorba et al. 2015). Further efforts should be directed at understanding these molecular 
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interactions and improving molecular tools for increasing production of foreign proteins in 
plants that may improve crop production.  
As stated before biopharming requires tools to increase recombinant protein expression. One 
way is the use of silencing suppressors as well as replicating vectors to manipulate these 
components to improve protein expression. 
Tools to improve construction of expression vectors 
Plant synthetic biology has paved the way to ensure that plants and algae are engineered to 
be more useful by producing therapeutic compounds, addressing food insecurity and 
ecosystem contamination (Patron et al. 2015). Assembling different DNA components in high 
throughput manner is essential to the advancement of plant synthetic biology. The first 
introduction of standardisation was the development of BioBrick™, a DNA unit that is flanked 
by standardised sequences to ease the assembly with other BioBrick parts (Knight 2003). The 
parts contain certain sequences called a prefix and a suffix that determine which parts are 
compatible. BioBricks made it possible to store, share and assemble these modular biological 
parts in different combinations (Knight 2003; Ellis et al. 2011; Patron et al. 2015). However, 
the disadvantage of BioBricks is the 8 bp scar (nucleotides left after using other assembly 
methods) sequence which affects assembly of fusion proteins and ribosomal binding sites 
(RBS) (Ellis et al. 2011). Many other BioBrick assemblies have been developed to compensate 
for the limitations of the first BioBricks standards, including BglBricks which is described to 
reduce the amount of scar sequences to 6bp (Phillips & Silver 2006; Anderson et al. 2010). 
Furthermore, Gateway cloning (Hartley et al. 2000) and Clonetech In-Fusion, a recombinase-
based cloning technology is described as highly efficient but also leaves behind a 21 bp scar 
sequence. In addition, other cloning methods such as the Uracil-Specific Excision Reagent 
Fusion and especially Gibson Assembly were limited because plasmids became less efficient 
at larger sizes and a high error rate was observed during PCR amplification of 10 kb constructs 
(Geu-Flores et al. 2007; Gibson et al. 2009).  
Assembly methods based on Type II restriction enzymes (RE) have been used to overcome 
the challenges of larger constructs. These enzymes cut outside their recognition sequence 
which generates overhangs that are different to that of the recognition sequence (Lippow et 
al. 2009). This is particularly useful when assembling other fragments with matching 
overhangs and results in a DNA product without any scar sequences. Golden Gate is a DNA 
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cloning method based on these Type II REs producing 4 bp overhangs that can be ligated with 
T4 ligase (Engler et al. 2008; Engler et al. 2009). This standardised modular cloning is 
efficiently performed in a single tube resulting in ‘scarless’ assemblies that are assembled 
together in a defined linear order. A limitation of this method is the removal of internal Type 
II enzymes sites from starting modules, which makes Golden Gate a non-reusable system 
(Engler et al. 2014). To overcome this, a “Golden Gate Modular Cloning (MoClo) Plant Parts 
Kit was developed. In addition, another strategy called GoldenBraid was introduced to allow 
reusability of these Golden Gate parts (Sarrion-Perdigones et al. 2011). Both methods allow 
for the construction of transcriptional units (TU) from basic parts which can further be 
assembled into specifically designed destination plasmids. GoldenBraid 2.0 was then 
developed to address key issues such as sharing common standard parts with other users, 
optimizing its speed and efficiency and making software and hardware more user friendly 
(Sarrion-Perdigones et al. 2013). Modular cloning methods are becoming popular among 
plant biologist since they allow for the construction of multigene constructs from pre-made 
or shared DNA parts. Recently, researchers were able to adapt the RNA-guided Cas9 system 
to GoldenBraid. The workflow and software tools were designed and optimized for the gRNA 
construction and can be accessed on the GB resource site. A transient expression assay was 
performed in N. benthamiana to determine the functionality and the efficiency of gRNA–Cas9 
GB tools (Vazquez-Vilar et al. 2016). 
Furthermore, these vectors and the different components described above can be used to 
address the threats of emerging infectious diseases such as Zika virus. 
Significance of Zika virus expression in plants 
The Zika virus (ZIKV) epidemic which started in 2015 has affected millions of people, especially 
those in Brazil and has had a major impact on global health and international travel. The virus 
has also been associated with microcephaly and other birth defects in new-borns and 
Guillain–Barré syndrome in adults (Powers et al. 2016). The World Health Organization (WHO) 
declared the outbreak as a Public Health Emergency of International Concern (Poland et al. 
2018). Since then researchers across the world have been trying to understand and develop 
vaccines against ZIKV.  
ZIKV is an arbovirus belonging to the Flavivirus genus which includes other clinically important 
arboviruses such as dengue (DENV), Japanese encephalitis virus (JEV) and West Nile virus 
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(WNV) (Lanciotti et al. 2008). The Zika virion is an enveloped icosahedron and contains a non-
segmented, ssRNA (+) genome. The genome encodes three structural proteins, the capsid (C), 
pre-membrane and envelope protein (PrME), membrane protein (M)  and seven non-
structural proteins (Baronti et al. 2014). The virus is transmitted by Aedes aegypti mosquitoes 
and has spread across 85 countries (www.who.int).  
One of the obstacles faced by researchers in the field of vaccine development is considerable 
cross reactivity that has been detected between ZIKV and other flaviviruses. This is 
particularly important for vaccine development in areas where other flaviviruses are also 
endemic (Priyamvada et al. 2016). Furthermore, antibody-dependent enhancement (ADE) of 
ZIKV antibodies is yet to be determined. ADE is a result of antibodies from a previous serotype 
facilitating the infection of a second serotype which results in a more detrimental disease. At 
present there are many ZIKV vaccine candidates in development which are based on various 
technologies ranging from live virus to protein-nanoparticle conjugates; however, a 
commercial vaccine will not be ready in the medium term (Lazear & Diamond 2016). It is 
therefore a priority to develop measures to control or limit the spread of ZIKV disease.  
There is a crucial need for a highly specific diagnostic assay  to ensure that case management, 
surveillance, control, and vaccine trials are carried out efficiently (Goncalves et al. 2018). 
Assays for ZIKV detection requires equipped laboratory facilities with diagnostic competent 
personnel (Waggoner & Pinsky 2016). Reverse transcription-PCR (RT-PCR)-based assays 
remains the gold standard for ZIKV RNA detection and distinguishing between other 
flaviviruses. In addition, viral RNA has a longer duration in body fluids (urine and saliva) than 
serum, increasing the rate of detection using RT-PCR (Musso et al. 2015; Gourinat et al. 2015; 
Waggoner & Pinsky 2016).  However, current serological assays require more rigorous testing 
and increased specificity through decreasing cross reactivity. 
Another method is the production of high affinity monoclonal antibodies (MAbs) to recognise 
specific ZIKV antigens which are required for an antigen detection assay. MAbs have the 
ability to bind to molecular structures with high affinities and are also available in different  
quantities as homogeneous reagents (Rose et al. 2016; Sørensen 2010). MAbs are generated 
by immunizing animals, usually mice, with a target antigen. These target antigens such as 
proteins are recombinantly expressed and purified in traditional systems such as Escherichia 
coli, yeast and mammalian expression systems (Sørensen 2010). ZIKV was primarily identified 
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via neutralizing antibodies in human sera. Due to high level of cross reactivity with other 
flaviviruses which gave a false positive result, the centre for disease control (CDC) warned 
that ZIKV infection cannot be confirmed with serological data only. Furthermore, though 
several Dengue NS1 antigen assays have been developed, antigen detection assays are not 
available yet (Waggoner & Pinsky 2016; Goncalves et al. 2018).  
Assays to detect the Zika pathogen would rely on Nucleic-Acid Testing and high-affinity 
monoclonal antibodies that recognize specific epitopes on ZIKV antigens. Simpler RT-PCR 
methods such as cartridge based assays that can simultaneously detect ZIKV and other 
arboviruses from a single specimen in <2 hours have the ability to be used at or near the point-
of-care (Goncalves et al. 2018). The development of more-portable molecular platforms for 
detection of ZIKV and other arboviruses includes recombinase polymerase amplification  and 
loop-mediated isothermal amplification (Teoh et al. 2015). Other interesting technologies are 
also based on clustered regularly interspaced short palindromic repeats (CRISPR) and the use 
of paper-based strips for ZIKV detection (Niwa et al. 2014).  
The cross-reactivity problem makes flavivirus antibody detection tools unreliable. 
Interestingly virus-specific neutralizing antibodies collected during the late convalescent 
phase (i.e. >2 months) had very little cross reactivity (Collins et al. 2017). This highlighted the 
importance of timing of collected samples for serological assays. Another method called ZIKV 
NS1 blockade-of-binding (BOB) ELISA showed high specificity and sensitivity and is used in 
laboratories in six different countries (Balmaseda et al. 2017). Nanotechnologies have also 
been developed for rapid ZIKV and DENV antibody or antigen detection. 
ZIKV is a public health concern and the development of new diagnostic assays and platforms 
must be encouraged. It is essential that a product is available to use in the field, it must be 
robust, easy to use, cheap, and accurate and it must have demonstrable clinical impact. A 
platform such as biopharming would be invaluable to speed up ZIKV detection. Many other 
flavivirus proteins have been expressed and purified from plants. A plant-made WNV vaccine 
candidate, the domain III of the E protein produced in N. benthamiana, elicited a potent 
immune response in mice (He et al. 2014). Plant-produced WNV proteins and MAbs are able 
to identify and detect human IgM responses to WNV infection, in serological assays. 
Furthermore, Yang et al. (2017a) were able to generate plant-produced ZIKV E proteins that 
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bind to a range of MAbs that recognize various ZIKV E conformational epitopes and are highly 
immunogenic.  
The need for a ZIKV detection system and a vaccine is still a high concern for public health. 
Funding and efficient platforms such as biopharming could speed up the process and prevent 
any further outbreaks.  
Project aims and objectives 
Biopharming is a promising platform for the production of recombinant proteins for use in 
the development of vaccine candidates and therapeutic agents. However, low protein yield is 
still an ongoing problem. The overall aim of this project was to increase protein expression by 
manipulating the DNA components to improve plant expression vectors.  
Silencing suppressor proteins have been shown to help with the accumulation of recombinant 
proteins. The first objective was to determine which of the silencing suppressors that are 
currently being used in our lab generate the highest protein expression. This was determined 
by evaluating the level of the EGFP produced from pEAQ-HT and pRIC 3.0 with either P19, 
NSs, TAV 2b and the alphasatellite rep as the silencing genes.  
The second objective was to assemble an optimized replicating plant expression vector with 
the addition of the best silencing suppressor. This was done by using replicating machinery, 
rep, from three different viruses, namely the bean yellow dwarf virus (BeYDV), beak and 
feather disease virus (BFDV) and begomovirus alphasatellite. The GoldenBraid cloning 
technique was used to assemble the replicating vectors and EGFP expression was used to 
determine the best expression vector.  
Finally, to determine the efficacy of these replicating vectors, the attempt was made to 
express the ZIKV pre-membrane and envelope (PrME) protein in plants. Expression of the ZIKV 




Chapter 2: Investigating the effect of silencing suppressor activity on 
EGFP expression in plants 
2.1. Introduction 
Molecular farming is a cost-effective platform which makes use of plants for the expression 
of recombinant proteins. The practice of expressing recombinant proteins in plants is 
recognised worldwide. Recombinant proteins were originally produced in bacterial and yeast 
cells, mammalian cell lines and insect cells (Fischer et al. 2004; Twyman et al. 2003; Sabalza 
et al. 2014). Plants have many advantages since they are safe and inexpensive and can easily 
be scaled up to agricultural levels. They are also capable of post translational modification of 
the recombinant proteins required for their optimal activity. However, one of the shortfalls 
of molecular farming is the often lower yield of recombinant proteins in plants than is 
achieved in mammalian cells (Sabalza et al. 2014). The protein yield is affected by genetic, 
epigenetic, biochemical and environmental factors. Product yield can be influenced by 
genetic factors such as the efficiency of mRNA production, mRNA turnover and the efficiency 
of protein synthesis. Furthermore, different biochemical factors can affect protein 
accumulation such as subcellular localization by targeting the protein to the ER using signal- 
or retention sequences (Zimmermann et al. 1998). Another method to increase protein yield 
is the use of viral silencing suppressor proteins.  
Viruses are one of the main causes of diseases in plants and animals. In plants, infection can 
cause major crop losses by stunting growth, yellowing, necrosis and other abnormalities 
(Wang et al. 2012). However, plants have developed a major antiviral defence mechanism 
called RNA silencing that targets and degrades foreign RNA molecules. This process is also 
known as post transcriptional gene silencing (PTGS) (Figure 1). RNA silencing involves an 
RNase III-like enzyme, DICER, that processes dsRNA into 21-25 nucleotides (nt) and produces 
small interfering RNAs (siRNAs) (Hammond et al. 2000). siRNAs activate the RNA-induced 





Figure 1: Virus induced RNA silencing. The figure represents a simplified model of the plant RNA silencing where 
double stranded (ds) RNA can be made by RdRP (RNA dependent RNA polymerase) and then diced up into 21–
24 nt siRNAs. Viral siRNAs activate RISC complex for target cleavage or translational arrest (Palukaitis et al. 2008). 
Figure reproduced under the fair-use policy of the University of Cape Town. 
 
These siRNAs are also responsible for systemic signalling and transcriptional silencing. Plant 
viruses are strong inducers and targets of virus induced gene silencing (VIGS) because the 
majority have RNA genomes and replicate via dsRNA intermediates (Palukaitis et al. 2008). 
This shows that an inducer can target degradation against itself and other high levels of 
foreign RNA (Johansen 2001). On the other hand, plant viruses have evolved strategies to 
counter this defence mechanism using viral proteins that inhibit PTGS (Silhavy & Burgyán 
2004; Li & Ding 2001).  
Viral suppressor proteins target step in the PTGS pathway suggesting that they evolved 
independently (Figure 2). Depending on the which step the proteins interfere with they can 
be placed into one of three groups. The first group inhibits PTGS in all the tissues of the plant 
which inhibits the accumulation of the processed 21-25 nucleotides RNAs (Mallory et al. 
2001). The potyvirus-encoded helper component proteinase (HC-Pro) included in this group 
was one of the first viral proteins to be identified as a suppressor of PTGS (Palukaitis et al. 
2008) (Figure 2). The second group, which includes cucumber mosaic virus protein 2b 
(Cmv2b), has no effect on tissues that have already activated PTGS but prevents the spread 
to emerging plant tissue. Studies suggest that Cmv2b protein blocks a nuclear step of PTGS 
that is critical for silencing suppression activity (Lucy et al. 2000; Chicas & Macino 2001). The 
third group includes the potato virus X p25 protein which has been suggested to block the 
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synthesis of the silencing signals, thereby preventing the spread of silencing (Voinnet et al. 
2000; Chicas & Macino 2001). The literature about silencing suppression is still limited; 
however, a few viral suppressor proteins have been studied.  
 
 
Figure 2: A model for transgene PTGS suppression. Transcription of a transgene results in production of dsRNA 
via cellular RdRp. The dsRNA is degraded by Dicer, an RNaseIII-like enzyme into 21- to 25-nucleotide RNAs (si 
RNAs). The silencing complex is induced for mRNA degradation. NSs could interfere with a step(s) for generating 
the dsRNA. HC-Pro suppression of silencing occurs at a step before accumulation of the small RNAs. TBSV p19 
binds siRNAs.  
 
Tomato spotted wilt virus (TSWV) species belongs to the Tospovirus genus within the 
Bunyaviridae family of multicomponent ssRNA viruses. The virus multiplies in insect cells and 
is transmitted by many thrips species (Adkins, 2000). The virus genome consists of three 
negative sense or ambisense ssRNA molecules. The negative sense L RNA (8.9 kb) encodes 
the L protein, a putative RNA dependent RNA polymerase (RdRP). The ambisense M RNA (4.8 
kb) encodes the putative movement protein (NSm) and structural proteins. The ambisense S 
RNA (2.9 kb) encodes the nucleocapsid and NSs protein (Haan et al. 2016; Kormelink et al. 
1993). The NSs protein is found mainly in the cytoplasm of plants infected with TSWV and the 
amount correlates with the severity of symptoms in infected plants. Takeda et al. (2002) 
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transient suppression assay that showed that the NSs protein suppressed sense transgene-
induced PTGS. This suggests that NSs interferes with the step(s) before the plant’s RdRP is 
able to synthesise dsRNA.  
Tomato bushy stunt virus (TBSV), a unique RNA virus species, is a member of the 
Tombusviridae family. TBSV contains a 4.8 kb positive sense ssRNA genome that encodes five 
open reading frames (ORFs) (Oster et al. 1998; Qu & Morris 2002). RNA viruses generally 
require the expression of the coat protein (CP) or systemic movement protein in order to 
move long distances in plants; however, TBSV was reported to spread in the absence of CP 
expression (Scholthof et al. 1993). P19, derived from single guide RNA (sgRNA)-2, has been 
shown to be involved in suppression of PTGS of transgenes in N. benthamiana (Figure 2) 
(Voinnet et al. 1999; Carrington et al. 2001). The P19 protein was also shown to dramatically 
enhance transient expression of a range of proteins (Voinnet et al. 2002). 
Tomato aspermy virus (TAV) is a species of the Cucumovirus genus that infects dicotyledonous 
and monocotyledonous plants. TAV has a segmented tripartite positive sense ssRNA genome. 
RNA-1 and RNA-2 encode proteins 1a and 2a which are involved in replication and internal 
transcription. RNA-3 and sgRNA-4 are translated into the movement and capsid protein. The 
viral suppressor of RNA silencing is encoded by ORF-2b (Salánki et al. 1997). Zhang et al. 
(2008) were able to show that the accumulation of 5ʹ secondary siRNA and the RNA-
dependent RNA polymerase (RdRP) was down-regulated by TAV 2b (Zhang et al. 2008). 
Protein yield is an important factor in biopharming and determined by many other factors, 
one of these being the use of a silencing suppressor protein. In the experiments reported here 
three different silencing suppressors - NSs, P19 and TAV 2b - were compared to test their 
effects on recombinant protein expression (Appendix A).  
2.2. Material and methods:  
Construct preparation 
The constructs pEAQ-P19-EGFP, pEAQ-TAV 2b-EGFP, pEAQ-NSs-EGFP pEAQ-No P19-EGFP, pRIC 
3.0 and pRIC 3.0-EGFP were maintained in DH5-α chemically competent E. coli cells (E. 
cloni™,Lucigen). Plasmids were obtained from the culture collection in the Biopharming 
Research Unit (MCB, UCT). The cells were streaked onto Luria-Bertani (LB) agar (0.5 % yeast, 
1 % tryptone, 0.5 % sodium chloride, 1.5 % agar) plates containing 100 μg/mL ampicillin and 
26 
 
left overnight (O/N) night at 37 °C. A single colony was picked and inoculated into 10 mL LB 
broth with 100 μg/ml ampicillin and incubated at 37 °C, for 16 to 18 hours (hrs) with agitation 
at 120 revolutions per minute (rpm). The plasmid DNA was extracted using the GeneJET 
Plasmid Mini-prep Kit (Thermo Scientific™, USA) as per manufacturer’s instructions followed 
by quantification using a Nanodrop (Thermo Scientific™ USA). 
 
2.2.1. Construction of vectors  
Subcloning EGFP into pRIC 4.0 
The EGFP gene was successfully cloned into the replicating plant expression vector, pRIC 4.0, 
which contain the TAV 2b silencing suppressor protein. The EGFP gene is a red-shifted variant 
of wild-type green fluorescent protein and has been previously shown to have a brighter 
fluorescence and higher expression in mammalian cells (BD Biosciences Clontech, CA, USA).  
PCR was carried out to amplify and add the restriction enzyme sites for cloning the EGFP gene 
into the pRIC 4.0. The sense primer contained a 5ʹ NcoI site before the start codon which is 
compatible with the vectors AflIII site, and the antisense primer contained the 3ʹ XhoI site 
downstream of the stop codon. The PCR mixture consisted of 1 x Phusion GC buffer, 200 µM 
dNTPs, 0.02 U/µL Phusion High-Fidelity DNA polymerase (Thermo Scientific), 0.5 µM GFP 
(NcoI) forward primer and 0.5 µM GFP (XhoI) reverse primer (Table 2) and 1 ng of pRIC 3.0-
EGFP in a final volume of 50 µL. The primers amplified a 570 bp PCR product that was the 
EGFP gene with incorporated RE sites. The thermocycling was performed using a MyCycler™ 
thermal cycler (Bio-Rad) and the parameters were as follows: an initial denaturation cycle for 
2 minutes at 95 °C was followed by 30 cycles of denaturation for 30 seconds at 95 °C, 30 
seconds at an annealing temperature of 55 °C, extension for 90 seconds at 72 °C and a final 
cycle comprising of an extension at 72 °C for 2 minutes. The PCR product was resolved on a 
TBE agarose gel containing 2.5 mg/mL ethidium bromide and visualised under long-
wavelength UV light (360 nm).  The PCR product was excised under long-wavelength UV light 
and gel purified using the QIAquick® Gel Extraction kit (Qiagen, Netherlands) as per 
manufacturer’s instructions. All enzymes used in this study were obtained from Thermo 





Table 2: Primers used in this study as well as melting temperature (Tm) and PCR product size  
Name Forward Reverse Tm (°C) Product size  
EGFP  TCGAGCACCATGGTG AGC AA CCGCTCGAGTTACTTGTACAGCTCGTC 55 738 bp 
EGFP Int  CGTAAACGGCCACAAGTT  GTGCTCAGGTAGTGGTTG  53 585 bp 
pTRA CATTTCATTTGGAGAGGACACG GAACTACTCACACATTATTCTGG 53  
*The restriction enzyme sites are represented by the underlined section in primer sequence 
The DNA of pRIC 4.0 was retrieved from a glycerol stock in the BRU lab culture collection. The 
culture was streaked onto a luria agar (LA) plate with ampicillin (100 µg/ml) and incubated 
O/N at 37 °C. A single colony was subsequently inoculated in 10 ml LB with ampicillin (100 
µg/ml) and incubated O/N with shaking. The DNA was extracted using the GeneJET Plasmid 
Mini-prep Kit (Thermo Scientific ™, USA) as per manufacturer’s instructions. The vector DNA, 
pRIC 4.0 was linearised with AflIII and XhoI for 1 hour and 30 minutes at 37 °C. The DNA 
product was purified as described above. The vector was then dephosphorylated with rAPID 
alkaline phosphatase as per manufacturer’s instructions (Roche; Sigma-Aldrich).  
The purified EGFP PCR product was digested with NcoI and XhoI for cloning into pRIC 4.0. After 
incubation for 1 hour at 37 °C, the DNA fragments were gel purified as described above. 
Ligation was performed using T4 DNA ligase from the Quick Ligation™ kit protocol (BioLabs® 
Inc.) with a 1:3 ratio of vector to insert in final volume of 20 μL. The mixture was incubated at 
room temperature for 5 minutes as per manufacturer’s instructions. 
 
Transformation 
DH5-α chemically competent E. coli cells (E. cloni™, Lucigen) were transformed with a tenth 
of the ligation volume (2 μL) following the heat shock method (Sambrook and Russel 2001) 
and placed on ice for 15 minutes. The cells were heat shocked at 37 °C for 60 seconds and 
then placed on ice for 2 minutes. The cells were incubated with 500 μL of LB for 1 hour at 37 
°C with shaking. Thereafter the pRIC 4.0-EGFP cells were plated onto LB agar plates with 




Screening of positive clones 
Colony PCR was used to screen for recombinant clones containing egfp. The PCR amplified a 
546-bp region within egfp. A total volume of 40 μL was used for the reaction and reagent 
concentrations were: 10 pmol/μL per EGFP Int primer (Table 2), 1.5 mM MgCl2, 1 x GoTaq® 
Reaction Buffer, 0.2 mM dNTPs and 1.25 U GoTaq® DNA polymerase (Promega Madison, 
USA). The primers were designed to amplify a 546 bp DNA product internal to the EGFP gene. 
The thermocycling was performed using a MyCycler™ thermal cycler (Bio-Rad) and the 
parameters were as follows: an initial denaturation cycle for 2 minutes at 95 °C was followed 
by 30 cycles of denaturation for 30 seconds at 95 °C, 30 seconds at the annealing temperature 
of 53 °C, extension for 35 seconds at 72 °C and 1 cycle comprising of a final extension at 72 °C 
for 5 minutes. The PCR products were visualized on a 1 % agarose gel to determine the 
positive colonies. The positive clones were picked from the agar plate and inoculated in 10 
mL LB with appropriate antibiotics. The plasmid DNA was extracted using the GeneJET Plasmid 
Mini-prep Kit (Thermo Scientific™, USA) as per manufacturer’s instructions followed by 
quantification using a Nanodrop (Thermo Scientific™ USA). RE digest with EcoRV and XhoI for 
1 hour at 37 °C was carried out to confirm the size of the construct and fragments were 
resolved by gel electrophoresis on 1% TBE agarose gel. Clones were further confirmed by 
sequencing analysis (Macrogen Inc.) using pTRA sense and pTRA antisense primers (Table 2).  
 
Agrobacterium tumefaciens 
Agrobacterium tumefaciens strain GV3101, containing the helper plasmid pMP90RK, was 
used in the transformation of the pRIC 4.0-based construct. The cells were streaked out onto 
Luria-Bertani (LB) agar plates containing 50 μg/mL carbenicillin, 50 μg/mL rifampicin and 30 
μg/mL kanamycin for antibiotic selection and grown for 2-3 days at 27 °C. Thereafter, single 
colonies were grown in 10 mL LB broth with 50 μg/mL carbenicillin, 50 μg/mL rifampicin and 
30 μg/mL kanamycin at 27 °C, for 2-3 days with agitation at 120 rpm. 
 
Electroporation and back transformation 
Competent A. tumefaciens GV3101::p90RK cells were prepared as described by Wen-jun and 
Forde, (1989). Three hundred nanograms of the relevant construct was mixed with 100 μL 
competent cells in a chilled 0.1 cm electroporation cuvettes (Bio-Rad) and left on ice for 5 
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minutes (Maclean et al. 2007). The cells were electroporated under 1.8 kV, 25 μF and 200 Ω 
thereafter placed on ice and 900 μL of LB added to the cuvette. The cells were pipetted into 
a sterile microcentrifuge tube and incubated at 27 °C for 2 hours. This was followed by plating 
the Agrobacterium on LA plates containing carbenicillin (50 μg/mL), rifampicin (50 μg/mL) and 
kanamycin (30 μg/mL) and incubation at 27 °C for 3 days. The transformants were screened 
as described above (Wen-jun & Forde 1989). 
Recombinant Agrobacterium was verified by back-transformation into E. coli. This was done 
by growing up 5 mL of the putative recombinant cells in LB containing the appropriate 
selection at 27 °C. The plasmid DNA was purified and transformed into competent E. coli as 
described above. Recombinant clones were confirmed by RE digest using XhoI and EcoRV. 
 
2.2.2. Infiltration into N. benthamiana 
Recombinant Agrobacterium cells were grown up in 10 mL LB with the appropriate antibiotics 
at 27 °C for 3 days to achieve an optical density at 600 nm (OD600) of between 0.50-1.00. Five 
millilitres of the O/N culture was transferred to 50 mL LBB media (0.25 % tryptone, 1.25 % 
yeast extract, 0,50 % NaCl, 1 M-(N-morpholino) ethanesulfonic acid [MES] at pH 5.6 and 200 
mM acetosyringone supplemented with carbenicillin (50 μg/mL) and kanamycin (30 μg/mL). 
The 50 mL cultures were incubated with agitation at 27 °C overnight. The O/N culture was 
diluted in infiltration media (10 mM MES [pH 5.6] and 20 mM MgCl2 supplemented with 200 
μM acetosyringone) for a final OD600 = 0.50. The Agrobacterium solution was infiltrated into 
the abaxial air spaces of 4-6-week-old N. benthamiana leaves using a needleless syringe. The 
plants were grown at 22 °C with 16-hour light and 8-hour dark photoperiods. 
2.2.3. Protein expression 
Protein extraction 
Total soluble protein was extracted for small scale expression studies. Briefly, three leaf discs 
were harvested using the inside of the top of a 2 mL microcentrifuge tube as a cutter. Two 
ceramic beads (Biogen) and 250 μL per leaf disc of 1 X phosphate buffered saline (PBS) with 
the inclusion of CompleteTM, EDTA-free protease inhibitor (Roche Diagnostics, SA) as per 
manufacturer’s instructions were added to the leaf discs. To remove particulate matter the 
samples were vortexed for 10 minutes, followed by centrifugation at 15 800 x g (≈ 13 000 
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rpm) for 5 minutes and this step was repeated. The final supernatant was then transferred to 
microcentrifuge tube. These clarified samples were stored at -20 °C prior to protein analysis. 
EGFP immunoblotting and fluorescence was standardised in that the same amount of fresh 
weight of plant material (same number of leaf discs) was used and that each sample was 
prepared identically.  
 
EGFP fluorescence 
EGFP fluorescence was quantified using a Glomax Multi+ Detection system (Promega, USA) 
with the blue optical kit as it excites the EGFP fluorophore with a maximum excitation 
wavelength of 460 nm and an emission wavelength of between 515-580 nm. A dilution series 
was made; 1:10 or 1:100, using sterile water and a 100 µL of each sample was loaded in 
triplicate into a black 384 well plate (Porvair, Whitehead Scientific). 
 
Statistical analysis 
Data were presented as mean and standard deviation (SD). ANOVA test or Student’s t test 
was used for statistical analysis. P <0.05 was considered statistically significant. 
 
SDS-PAGE and immunoblot analysis 
Samples were prepared by adding 5 x SDS sample application buffer (2 % SDS, 100 mM Tris-
HCl, pH 7.5, 2 mM EDTA, 52 % glycerol, 4.3 % β-mercaptoethanol, 0.25 % bromophenol blue) 
to a final concentration of 1 x and heated at 90 °C for 3 minutes. Equal volumes of the samples 
were resolved on a 12.5 % polyacrylamide gel by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) at 20 mA for ≈ 1 hour 30 minutes. The gel was transferred onto a 
nitrocellulose membrane by semi-dry blotting using a Bio-Rad Trans-Blot® Semi-dry transfer 
cell for approximately 90 minutes at 15 V. The membrane was then blocked with blocking 
buffer (10 x PBS, 2 % non-fat milk and 1 mL 10 % Tween-20) and incubated at room 
temperature for 30 minutes with gentle shaking. After removal of the blocking buffer, mouse 
monoclonal primary antibody (anti-GFP) (Sigma Aldrich®, Missouri, USA) diluted in blocking 
buffer (1:5000) was added to the membrane and probed for 2-4 hours at room temperature 
with shaking or O/N at 4 °C with shaking. The membrane was washed 4 x 15 minutes in 
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blocking buffer with shaking. It was then incubated in alkaline phosphatase-conjugated goat 
anti-mouse secondary IgG (SigmaAldrich, USA) at 1:5000 dilution for 2-4 hours at room 
temperature with shaking. The membrane was washed again 4 x 15 minutes in blocking buffer 
lacking milk, with shaking. The membrane was developed using 3-5 mL NBT/BCIP (nitroblue 
tetrazolium/5- Bromo-4-chloro-3-indoxyl-phosphate) phosphatase substrate (1-Component) 
(KPL, US) solution for 1 hour or until protein bands appeared after which the reaction was 
stopped using water. 
 
2.3. Results  
2.3.1. Vector construction  
The EGFP gene was cloned into pRIC 4.0 by adding NcoI and XhoI restriction enzyme sites to 
the 5ʹ and 3ʹ ends of the gene respectively, using PCR. The PCR product and the linearised 
vector were ligated and transformed into E. coli. One colony was observed after incubation 
and the 546 bp band was confirmed using colony PCR (Figure 3a). The DNA was subsequently 
extracted and digested with EcoRI and XhoI RE which resulted in the expected banding pattern 
of 7201 and 874 bp (Figure 3b). The construct was further confirmed by sequencing 
(Macrogen) which agreed with predicted sequences on CLC Main Workbench 6. The pRIC 4-
GFP was successfully electroporated into A. tumefaciens cells. A back transformation followed 
by colony PCR and RE digest was carried out to confirm that the correct DNA was 






Figure 3: pRIC 4.0-EGFP vector confirmation. (A) Gel electrophoresis of colony PCR products to confirm the 
insertion of EGFP into the pRIC 4.0 vector. A PCR product of 546 bp (lane 1) corresponded with positive control 
(+). Molecular weight marker (M) and no template control (-). (B) Restriction enzyme mapping of pRIC 4.0-EGFP 
using EcoRI and XhoI produced the expected DNA fragments of 7201 and 874 bp (lane3). Undigested DNA control 
(U), EcoRI (lane 1), XhoI (lane 2), EcoRI and XhoI (lane 3), empty vector (lane 4) 
 
2.3.2. Effect of RNA silencing suppressors on EGFP yield when transiently expressed 
from a non-replicating vector, pEAQ-HT 
A small-scale expression time trial was carried out to determine the effect of the different 
silencing suppressors on EGFP yield. The accumulation of EGFP over time in plants infiltrated 
with Agrobacterium suspension was visualized using UV- light 3, 5 and 7 days post infiltration 
(dpi). The negative control containing no silencing suppressor, pEAQ-No P19-EGFP, had very 
low visible fluorescence throughout the time trial experiment (Figure 4). 
Fluorescence was detectable for all the constructs although the intensity varied between the 
constructs. The least amount of green fluorescence was observed from the pEAQ-
alphasatellite-EGFP vector whilst pEAQ-P19-EGFP, pEAQ-TAV 2b-EGFP and pEAQ-NSs-EGFP 
had higher levels of fluorescence in the infiltrated leaves (Figure 4).  




Figure 4: Fluorescence detection using UV from leaves infiltrated with different silencing suppressors 5 dpi. Nicotiana. 
benthamiana leaves were infiltrated with pEAQ-alphasatellite-EGFP, pEAQ-No P19-EGFP, pEAQ-P19-EGFP, pEAQ-TAV 2b-
EGFP and pEAQ-NSs-EGFP at OD600 = 0.50. The plants were monitored for 7 days using UV light for green fluorescence 
detection.   
 
The EGFP fluorescence was analysed and for days 5 and 7 there was no significant difference 
between the fluorescence of the three constructs, pEAQ-P19-EGFP, pEAQ-TAV 2b-EGFP and 
pEAQ-NSs-EGFP (Figure 5). This correlates with fluorescence observation seen in Figure 4. 
Although no significant difference was observed for the three vectors, fluorescence was 
significantly higher than the negative control and pEAQ-Alphasatellite-EGFP throughout the 
experiment. The negative control had little to no fluorescence and remained low for the entire 
experiment. The fluorescence detected from pEAQ-Alphasatellite-EGFP was comparable to 
the negative control with no significant difference observed between the two. There was a 








































Figure 5: Fluorescence of plant-made EGFP in the presence of different silencing suppressors. Fluorescence from TSP extracts 
was measured 3, 5 and 7 days post infiltration with pEAQ-HT EGFP containing the silencing suppressors: P19, NSs, TAV 2b and 
alphasatellite Rep. A pEAQ-HT EGFP vector without a silencing suppressor served as a control. Each data point represents 




2.3.3. Silencing suppressor activity in replicating systems 
Three of the silencing suppressors showed the same enhancement in expression. Further 
investigations using a replicating vector focused on the smallest of the three proteins: TAV 
2b. A small-scale syringe infiltration was carried out to determine the optimal optical density 
(OD) for the highest expression. The TAV 2b cassette was cloned into the BeYDV replicating 
vector pRIC 3.0, providing expression in cis, to create pRIC 4.0. The new vector was compared 
to pRIC 3.0 with and without NSs (routinely used in the lab) that supplied in trans. An empty 
pRIC 3.0  vector was used as a negative control (Regnard et al. 2010). EGFP expression and 
accumulation over time was determined on day 1 and 7 post infiltration via immunoblot 
analysis (Figure 6) from N. benthamiana leaves that were infiltrated with A. tumefaciens at an 
OD600 = 0.50. An EGFP specific antibody was used to detect the EGFP protein band (~ 27 kDa) 
which was observed for all the constructs except for the negative control pRIC 3.0 which 
lacked the GFP gene. Day 7 post infiltration produced a greater band intensity than day 1 
which infers an increase in protein expression for all the vectors. Overall, pRIC 4.0-GFP 
produced a greater band intensity compared to all the other constructs. pEAQ-HT -EGFP band 
intensity is similar to the band intensity of pRIC 4.0-EGFP; however, according to the 
fluorescence results in Figure 5, the expression was still lower (Figure 6). 
 
Figure 6:  Immunoblots looking at the affect of two silencing suppressors, NSs in trans (routinely used in the lab) and TAV 
2b in cis, on EGFP expression from replicating vectors. A) Expression on Day 1 and 7 of pRIC 4.0 EGFP incorporating TAV 2b 





3.0 EGFP lacking a silencing suppressor and EGFP positive control (+). Molecular weight marker (M). B) The replicating vectors 
with silencing suppressors compared with the non-replicating control pEAQ-HT- EGFP incorporating the TAV 2b in cis. 
Immunoblots were standardised using equal volumes of crude plant extract. EGFP was detected using mouse monoclonal 
primary antibody anti-GFP (1:5000).]   
 
EGFP fluorescence was measured to determine the effect of silencing suppressor activity on 
EGFP protein expression levels (Figure 7). EGFP accumulation was the greatest when 
expressed from pRIC 4.0-EGFP containing the TAV 2b silencing suppressor with a 1.6-fold 
increase from day 3 to 7 post infiltration. Interestingly, there was no significant difference in 
EGFP expression levels between the control, pRIC 3.0 (empty vector) and pRIC 3.0-EGFP 
(Without any silencing suppressor). Furthermore, a slight increase is observed from day 3 to 
7 for pRIC 3.0-EGFP with NSs in trans and was 3.6-fold lower than pRIC 4.0-EGFP (TAV 2b in 
cis) on day 7. A significantly higher EGFP expression was observed from pRIC 4.0-EGFP 
compared to all the other constructs, while the positive control, pEAQ-TAV 2b-EGFP (TAV 2b 
in cis) remained relatively stable from day 3 to 7. 








pRIC 3-EGFP + pBIN-NS


































Figure 7:  EGFP accumulation using replicating plant expression vectors and comparing silencing suppressors. Fluorescence 
from TSP extracts was measured on 1, 3, 5 and 7 days post infiltration with pRIC 3.0 EGFP and pRIC 4.0 EGFP containing TAV 
2b. Controls include pRIC 3.0 without EGFP, pRIC 3.0 EGFP co-infiltrated with pBIN NSs and pEAQ-TAV 2b-EGFP. Each data 
point represents arithmetic mean of triplicates ± SD. A 2Way ANOVA was used to evaluate statistical significance, P values 







One way to potentially enhance expression of foreign genes in plants is the use of silencing 
suppressor proteins. RNA silencing in plants is an important antiviral defence mechanism; 
however, viruses have in turn developed proteins to counter this defence. This study looked 
at the effect of different silencing suppressors on GFP expression and accumulation in N. 
benthamiana.  
Silencing suppressors have been used successfully for recombinant protein expression in 
plants. Different suppressor proteins, however, will have different effects on protein 
expression. This study demonstrated that the pEAQ-P19-EGFP (TBSV) and the pEAQ-NSs-EGFP 
(TSWV) systems (Figure 5) had similar expression levels even though the two silencing 
suppressor proteins (P19 and NSs) affect different stages of PTGS (Takeda et al. 2002; Silhavy 
& Burgyán 2004). Antibody expression has been shown to be enhanced by the presence of 
the  TBSV P19 protein when compared to a P19 mutant (Saxena et al. 2011). Antibody 
production was increased between 3-5 fold when co-expressed with HCPro (757 mg/kg fresh 
weight) than those without (Vézina et al. 2009). P19 has also been used to enhance expression 
of several mAb as well as enzymes. Surprisingly the fluorescence from the negative control 
(i.e. pEAQ-NO P19-EGFP) was comparable to pEAQ-alphasatellite-EGFP. Alphasatellite Reps 
have been reported in the literature to have strong silencing suppressor activity (Nawaz-Ul-
Rehman et al. 2010). The researchers infiltrated EGFP-silenced leaves with virus or satellite-
encoded genes which were examined for reversal (suppression) of PTGS under UV 
illumination. Only the constructs expressing the alphasatellite Rep displayed a reversal of GFP 
silencing. The level of silencing suppression was comparable to that of P19 from TBSV. 
Although many begomoviruses and their associated satellites have been found to act as 
silencing suppressors, this was not evident in the current study. Not all satellite encoded Rep 
proteins have silencing activity, and a possible explanation for our results is that begomovirus-
associated alphasatellite Reps are phylogenetically distinct from Reps of other begomovirus-
associated alphasatellites. On the other hand, studies found that silencing suppression only 
takes place where there’s active virus and alphasatellite replication, suggesting that the 
alpha-Rep protein might have a short half-life (Nawaz-Ul-Rehman et al. 2010) 
The TAV 2b silencing suppressor greatly enhances EGFP expression at 5 dpi (Figure 5). The 
relative fluorescence of EGFP in the presence of TAV 2b was not significantly different than in 
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the presence of P19 and NSs, however P19 has been shown to increase symptoms of plant 
necrosis compared to TAV 2b (Yanez et al. 2017). The effect of TAV 2b on GFP expression 
could be explained by the fact that previous studies found that TAV 2b down-regulated the 
accumulation of RNA-dependent RNA polymerase (RdRP6) mRNA that is essential for the 
synthesis of secondary siRNA in plants during RNA silencing (Zhang et al. 2008; Moissiard et 
al. 2007). Moreover, the gene for TAV 2b is much smaller (≈ 287 bp) than the p19 (≈ 519 bp): 
this allows for the use of larger transgenes that won’t affect infiltration or expression. The 
smaller size also improves efficiency of the vector when expressing the protein of interest 
(Huang et al. 2009; Sainsbury et al. 2009). pEAQ-TAV 2b-EGFP seems to have a similar 
expression as pRIC 4-EGFP based on immunoblot analysis (Figure 6) which is the opposite of 
what is observed in figure 7. This could be an over saturation of the blot giving the appearance 
that pEAQ-TAV 2b-EGFP and pRIC 4-GFP have a similar expression. Furthermore, the 
standardisation of EGFP was done by using the same volume which would mitigate against 
the effect of the replicating vectors on the plant. Since replicating vectors are shown to affect 
the plant leaves leading to necrosis. Normalising to TSP on these leaves (probably lower 
amount of host proteins due to necrosis) and healthy leaves (normal concentration of host 
proteins) resulting in a higher difference in EGFP. Normalising to TSP assumes that there is no 
difference in the levels of host proteins.  
Another confusing result is the similar florescence between pRIC 3.0 (empty) and the pRIC 3-
GFP (without silencing suppressor). No expression was expected from the empty pRIC 3.0 
vector, but not for pRIC 3-GFP as it contains the EGFP gene.  This could mean that EGFP was 
not expressed or that the absence of a silencing suppressor compromised the plant health 
which affected expression; however, immunoblot analysis indicated that expression of EGFP 
was apparent on Day 7. Potential markers for plant health could be identified to test the effect 
of vectors with and without silencing suppressors on the health of the plant. Silencing 
suppressors have been shown to delay the onset of plant necrosis and chlorosis. Further 
studies will need to be carried out to confirm this.  
In conclusion, silencing suppressor proteins had a significant effect on EGFP expression level 
in this study, and an increase in gene copy number with a TAV 2b silencing suppressor can 
greatly enhance expression levels. The results confirm the increase in EGFP expression in the 
presence of a silencing suppressor protein. Expression is also greatly enhanced when a 
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replicating plant expression vector is used compared to a non-replicating vector. The results 
also provide evidence that the TAV 2b, P19 and NSs proteins are effective suppressors of GFP 
silencing. 
 
Chapter 3: Viral replication and its effect on protein expression  
3.1. Introduction 
Deconstructed plant viral expression vectors have become a powerful molecular tool for the 
production of biopharmaceuticals. These viral vectors are capable of producing high levels of 
plant-produced proteins within a short period of time (Hefferon 2017).  
The replication mechanisms of plant viruses have been exploited by molecular biologists to 
increase the expression of plant-produced biopharmaceuticals. Single-stranded RNA (ssRNA) 
viruses are predominant among plant viruses; however, ssDNA plant viruses are also 
becoming of greater importance in molecular biology and plant pathology. ssDNA viruses such 
as tomato yellow leaf curl virus (TYLCV), African cassava mosaic virus (ACMV) and bean yellow 
dwarf virus (BeYDV) belonging to family Geminiviridae have an important impact on the 
economy and are convenient for developing expression vectors (Hefferon 2014a; Scholthof 
et al. 2011). BeYDV belongs to the Mastrevirus genus and like other mastreviruses, has a 
single-component circular ssDNA genome (Figure 8) (Zhang et al. 2001). BeYDV has been 
utilized for production of monoclonal antibodies to Ebola, Zika and West Nile virus as well as 
for the production of novel encapsidated HPV pseudovirions (PsVs) in tobacco plants 
(Lamprecht et al. 2016; Huang et al. 2009). The BeYDV genome replicates via RCR with the aid 
of replication associated proteins (Rep/RepA). Its small simple genome can rapidly be 
amplified to very high copy numbers that can easily be manipulated, making it an attractive 
plant expression vector (Ward et al. 1988).  
The viral genome contains a short intergenic region (SIR) which encodes the transcription 
termination signals and the DNA primer binding sites for complementary strand DNA 
synthesis (Figure 8). The replication associated gene (rep) is situated adjacent to the long 
intergenic region (LIR) that contains the bidirectional promoter and stemloop structure to 
which the Rep/RepA binds (Chen et al. 2011). The LIR and SIR are the two cis-acting elements 
that allow for successful BeYDV replication (Liu et al. 1998). Rep and RepA are the two 
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important regulatory proteins involved in replication. Rep is translated from spliced mRNA 
and is responsible for initiating RCR whereas RepA is translated from unspliced mRNA. Rep is 
the only protein required for replication but in the presence of RepA, replication is more 
efficient (Hefferon & Dugdale 2003; Zhang et al. 2001). Other proteins encoded include the 
movement protein (MP) and coat protein (CP) which are important for systemic spread and 
viral movement (Liu et al., 1998).  
 
Figure 8: Bean yellow dwarf viral ssDNA circular genome structure. The BeYDV rep encodes the proteins Rep/RepA. BeYDV 
short intergenic region (SIR); long intergenic region (LIR) that contains the bidirectional promoter and stemloop structure. 
Movement (MP) and coat proteins (CP) (Chen et al. 2011). Figure reproduced under the fair-use policy of the University of 
Cape Town 
 
Regnard et al. (2010) designed a novel self-replicating expression shuttle vector, pRIC (Figure 
9), based on a mild strain of the BeYDV (BeYDV-m) (Halley-Stott et al. 2007). The vector was 
shown to increase transgene expression through replicational increase in transgene copy 
number of the human papillomavirus type 16 (HPV-16) major capsid protein (CP) and human 
immunodeficiency virus type 1 subtype C (HIV-1C) Pr55 Gag-derived p17/p24 antigen. In 
addition, the enhanced green fluorescence protein (EGFP) was used as an expression marker 
in N. benthamiana. The vector differs from other BeYDV-derived vectors by the presence of a 
rep gene in cis rather than in trans. This allows the vector to replicate independently, 
increasing the gene copy number and in turn increasing protein expression. The BeYDV coat 
protein (CP) and movement protein (MP) genes were replaced with an antigen-encoding 




Figure 9: Schematic diagrams for the plant expression vector, pRIC. Circularized replicon after release from T-DNA and 
Agrobacterium vector, pRIC. ColE1 ori, origin of replication for Escherichia coli; RK2 ori, origin of replication for Agrobacterium 
tumefaciens; bla, ampicillin ⁄ carbenicillin-resistance bla gene; LBLeft (LB) and right (RB) borders for T-DNA integration. The 
BeYDV rep gene that encodes the proteins Rep/RepA is placed in cis rather than in trans. BeYDV short intergenic region (SIR); 
long intergenic regions (LIR) that contain the bidirectional promoter and stemloop structure. SAR, scaffold attachment region 
of the tobacco Rb7 gene; p35SS, CaMV 35S promoter with duplicated transcriptional enhancer; CHS, chalcone synthase 5´-
untranslated region; pA35S, CaMV 35S polyadenylation signal. The grey bar represents the T-DNA transferred into the plant 
cell. Black arrows represents primer binding sites. (Regnard et al. 2010). Figure reproduced under the fair-use policy of 
the University of Cape Town 
 
Other replicating DNA viruses: alphasatellites and beak and feather disease virus (BFDV) 
Animal viruses such as the beak and feather disease virus (BFDV) and porcine circovirus (PCV) 
are part of the Circoviridae family and they also contain closed circular ssDNA. BFDV belongs 
to the Circovirus genus, which includes the smallest self-replicating mammalian viruses known 
(Delwart & Li 2012). BFDV infects wild and captive psittacine birds (Rahaus & Wolff 2003; 
Ortiz-Catedral et al. 2010) . The disease ranges from the acute form seen in neonates to a 
chronic form that is mostly observed in adult birds (Fogell et al. 2016). BFDV has a relatively 
simple but compact circular ssDNA ambisense genome of approximately 2,000 nt’s. The 
genome encodes the replication initiator protein (Rep) required for the initiation of 
replication and the capsid protein (CP). The intergenic region contains the origin of replication 
and the octanucleotide stem loop structure.  The replication mechanism of circoviruses is 
similar to that of geminiviruses (Faurez et al. 2009; Delwart & Li 2012). It is postulated that it 
replicates via RCR through double stranded intermediates.  
Alphasatellites are small circular DNAs that are capable of self-replication but which require 
a helper virus such as begomoviruses (family Geminiviridae) for dissemination, encapsidation 
and vector transmission (Nawaz-ul-Rehman & Fauquet 2009). The alphasatellite genome is 
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approximately 1380 bp in size and consists of one gene that encodes the Rep protein (alpha-
rep) followed by an adenine rich region (A-rich) and a hairpin structure (Briddon et al. 2004). 
RCR is a common feature shared between alphasatellites and geminiviruses, as well as the 
stemloop structure and a nonanucleotide origin of replication (Nawaz-Ul-Rehman & Fauquet 
2009). In addition, Nawaz-Ul-Rehman et al. (2010) have shown that Rep potentially acts as a 
suppressor of post transcriptional gene silencing (PTGS) (Nawaz-Ul-Rehman et al. 2010).  
Circoviruses such as BFDV share an evolutionary link with geminiviruses (Niagro et al. 1998). 
The non-coding regions and particularly the stem-loop structure are strikingly similar to those 
in the geminivirus genomes. Hexanucleotide repeats were found to flank the stemloop 
structure of BFDV and showed similarity with the geminivirus Rep binding site (Mankertz et 
al. 1998; Niagro et al. 1998). The high similarity of the Rep protein between the circoviruses 
BFDV and PCV with those of geminiviruses infers a phylogenetic relationship, and suggests 
that the Rep protein from these viruses originated from a common ancestor (Timmermans et 
al. 1992). Geminiviruses evolved along with their satellite circular ssDNA (Nawaz-ul-Rehman 
& Fauquet 2009). Their transcription regulation has been widely studied and some promoters 
have shown constitutive expression while others are more regultated (Zhang et al. 2012). 
This study aimed to improve expression in plants based on the replication machinery of 
BeYDV and other replicating ssDNA genomes (BFDV and alphasatellites). To ease the 
designing and production of the replicating vectors, the GoldenBraid (GB) cloning technology 
was used to standardise the pRIC 3.0 replicating parts. The assembly of large DNA constructs 
from smaller fragments has seen significant developments in synthetic biology over the years. 
In addition, speed and efficiency is a crucial feature for any cloning strategy including the 
ability to reuse DNA parts (Ellis et al. 2011; Sarrion-Perdigones et al. 2013; Gibson et al. 2009; 
Hartley et al. 2000). GB cloning allows for exchange of standard DNA parts to facilitate the 
construction of complex multigene structures using specific type IIS restriction enzymes, BsaI 
and BsmBI (Engler et al. 2008; Sarrion-Perdigones et al. 2011). Previous assemblies such as 
the Golden Gate technique allowed for standardisation however, these standard parts were 
not able to be used for subsequent assemblies (Engler et al. 2008; Engler et al. 2014). To solve 
this GB makes use of a first level destination plasmid, α, that becomes the entry plasmid for 
the second level destination plasmid, Ω. The type IIS RE cut a few base pairs away from the 
recognition site resulting in a 4 bp overhang flanking each DNA part. The flanked DNA parts 
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define each part´s relative position in the multipartite assembly and can efficiently be joined 
together via the compatible overhangs. The 4 bp overhang determines the order of each part 
in the final assembly (Figure 10) (Sarrion-Perdigones et al. 2013). The GB restriction-ligation 
cycles and type IIS RE enzymes ensure the stability of the desired assembly, thus making these 
cycles more efficient than the classical two steps of restriction and ligation (Alonso and 
Stepanova 2015). The technique is based on same enzymatic reaction as MoClo, a modular 
cloning system that differs by the addition of an extra level (level 0) for cloning of ‘subparts’ 
(Weber et al. 2011). 
 
Figure 10: The GB schematic of the 4 nt code for each part in the assembly. The nt code determine the position of each GB 
part to ensure correct assembly. Thorough planning needs to be done to decide where each part is placed and multiple parts 
can be made based on this diagram. E.g. defined functional regions: complete promoter region or full coding region. Image 
from GB cloning website - https://gbcloning.upv.es/search/ 
Figure reproduced under the fair-use policy of the University of Cape Town 
 
In order to further improve protein expression from pRIC 3.0, it is postulated that regulation 
of replication of the BeYDV-derived vector may be required to increase protein expression. 
Previous studies have shown that pRIC 3.0 can amplify the gene of interest via a 100x to 1000x 
increase in transgene copy number (Figure 9). The problem with this is, that although the 
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vectors strongly enhance gene expression at a transcriptional level, protein accumulation only 
increases 1.5- to 7-fold (Regnard et al. 2010). Based on this, the aim was to construct 
replicating vectors using the replication machinery from BeYDV (plant virus), alphasatellites 
(plant) and BFDV (avian virus) to divert resources to protein translation. The vectors consist 
of the viral stem loop structure that contains a nucleotide motif recognised by Rep to initiate 
replication.  The idea is that when Rep from the plant virus binds to the stemloop structure 
of the avian virus, difference in the stemloop nucleotide sequence may result in fewer DNA 
replicons and potentially higher protein expression as a result. The EGFP gene was used as a 
control and to test vector efficacy between the different vectors.  
 
3.2. Material and methods:  
3.2.1. Construction of vectors  
GoldenBraid cloning method  
GB parts can be classified as: 
1) GB patches: DNA fragments obtained from PCR amplification to remove any internal 
type IIS RE sites and add the appropriate 4-nucleotide overhang (Figure 10) that 
defines their category within the transcriptional unit (TU) (Process known as 
Domestication). The primers are obtained from the GB Domesticator tool 
(www.gbcloning.org/do/ domestication). 
2) GB parts: The GB patches stored as inserts within a specially designed entry vector, 
the universal part domesticator (pUPD). 
3) GB destination vectors (pDGBs): can be categorise into two levels according to the 
enzyme that releases the transcriptional unit/ module and to their backbone: 
a. Alpha, α, level plasmids have kanamycin resistance and release the insert 
upon BsaI digestion used for multipart assembly. To streamline the process, 
five alpha level plasmids (pDB alpha 11, 12, 13, 14 and 2R) were designed by 
Dr Tomas Moravec (Institute of Experimental Botany, Czech Republic). All 
alpha level plasmids will generate identical 4 bp overhangs after cutting with 
BsaI (GGAG/CGCT). However, the difference comes in when removing 
assembled gene cassettes from the alpha level plasmids using BsmBI. Here, Dr 
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Moravec added 4 nucleotides in each alpha level plasmid to ensure that each 
assembled gene cassette is ligated in the correct order. The overhang at the 
end of 1st gene cassette will be the same as the overhang at the start of the 
next gene cassette (Table 3). In addition, the first 4 bp code of pDB-α11 
corresponds to the 1st code of A1 (Figure 10) while the last 4 bp code of pDB-
α14 corresponds to 2nd code of C1 (Figure 10), maintaining the original GB 
code. The pDB-α 2R is the only plasmid that allows the cassette to be in a 
reverse orientation (Table 3).  
b. Omega, Ω, level plasmids contain spectinomycin resistance and BsmBI sites 
used for the final assembly. 
All the destination plasmids contain 2 restriction/recognition site for the type IIS RE. The RE 
site and the recognition site are carefully placed in opposite directions on the destination 
plasmid and differ by the antibiotic resistant marker (Sarrion-Perdigones et al. 2011). 
  
Table 3: Table representing the 4 bp overhangs within the alpha level plasmids. The overhangs at the end 
allow for ease of the assembly order of the gene cassettes when cloning from alpha level to omega level. The 
overhang at the end of 1st gene cassette will be the same as the overhang at the start of the next gene 
cassette. pDB3-Ω2 is the plasmid used in the final assembly of GB cloning.  
 BsmBI cut Fwd BsmBI cut Rev 
pDB-α11 GGAG CCAT 
pDB-α12 CCAT GCTT 
pDB-α13 GCTT GGTA 
pDB-α14 GGTA GTCA 
pDB-α2R GTCA CGCT 
pDB3-Ω2 GGAG CGCT 
 
 
Domestication of GB patches  
The glycerol stocks containing the template sequence were selected from the Biopharming 
Research Unit (BRU) culture collection database, inoculated in 10 mL LB with appropriate 
antibiotics and DNA extracted using the QIAquick® DNA Extraction Kit (Qiagen®) as per 
manufacturer’s instructions. The appropriate 4 bp overhangs were selected and cloned as 
follows: The rep/RepA was cloned as a coding sequence (CDS) according to the convention, 
B3-B5 i.e. AATG-GCTT. The BeYDV LIR 1, BFDV IR and alphasatellite IR were cloned as A1-C1 
part, i.e. GGAG-CGCT. BeYDV LIR 2 as a promotor sequence according to the convention, i.e. 
A1-B2, GGAG-AATG, to fool the primer design tool, the internal stop codon was changed and 
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one base deleted so that the sequence length would be a multiple of 3. The SIR was cloned as 
conventional terminator, B6-C1, GCTT-CGCT (Figure 10). Primers were designed using the 
GBCLONING.org website. Each sequence was submitted to the GBCLONING.org domesticator 
program as a FASTA file. The program checks for the presence of internal type IIS RE sites and 
automatically designs mutagenic primers however, if there is a type IIS RE present two sets of 
primers will be produced (Table 4). The advantage of GB2.0 mutagenesis is that typically only 
one round of PCR is necessary and no gel purification step is necessary. The PCR mixture 
consisted of 10 pmol/μL of forward and reverse primers (Table 4), 1.5 mM MgCl2, 1x Phusion 
HF buffer, 3 % DMSO, 10 mM dNTP and 0.02 U/µL Phusion DNA polymerase (Thermo 
Scientific) and 1 ng of template DNA. In the case where two patches were amplified, 1 ng of 
each patch was added to the reaction mix. The thermocycling parameters using the 
MyCycler™ thermal cycler (Bio-Rad): an initial denaturation for 30 s at 98 °C, followed by 5 
cycles of denaturation for 10 s at 98 °C, anneal for 30 s at 58 °C and 20 s at 72 °C for extension. 
Another 25 cycles comprising of denaturation for 10 s at 98 °C, anneal for 30 s at 60 °C and 20 
s at 72 °C for extension and 1 cycle at 72 °C for 2 minutes. Two microlitres of the PCR mix were 
used for verification on a 1% agarose gel. Once the amplicons were verified, the remaining 40 


















Table 4: Goldenbraid primers used to amplify GB patches. RE sites (yellow), 4bp code for domestication only 
(grey) and 4bp convention for multipart assembly (purple) 
4 bp 
overhang 
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pMA BFDV 84A 
1.1mer 
(GQ165756) 






























To amplify from 
pUC57 
alphasatellite rep 
CaMV cassette  
GGAG-
CGCT 




To amplify from 
pRIC 4.0 vector 













To amplify from 
pUC57 
alphasatellite 
 pUPD2 CCCGATCAACTCGAGTGCCA  
 
GAGGAAGCCTGCATAACG Colony PCR and 
sequencing 
 pJET CGACTCACTATAGGGAGAGCGGC AAGAACATCGATTTTCCATGGCAG  
The table represents all the primer sequences used to amplify the specific genes. Primers were obtained from the 
gbcloning.upv.es website after submission of the template sequence.  
 
After the DNA extraction, the PCR products were cloned into the domesticator plasmid 
pUPD2. Reaction mix consisted of 80 ng of column-purified PCR product and 40 ng of pUPD2, 
1 μL of BsmBI (Thermo Scientific), 1 U T4 ligase, 1X T4 ligase buffer (Thermo Scientific) in a 
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final volume of 10 µL. All the RE used in this study were purchased from Thermo Scientific. 
The thermocycling parameters using the MyCycler™ thermal cycler (Bio-Rad): initial digestion 
cycle for 20 minutes at 37 °C, followed by 45 cycles of restriction-ligation reaction for 2 
minutes at 37 °C and 5 minutes at 16°C. Final digestion of excess destination plasmid for 30 
minutes at 37 °C and deactivation of the enzymes for 20 minutes at 80 °C.  Two microlitres of 
the restriction-ligation reaction mix were used to transform DH5-α chemically competent E. 
coli cells (E. cloni™,Lucigen) and plated onto Luria broth (LB) agar plates with chloramphenicol 
(CAM) (20 µg/mL). DH5α E. coli do not require IPTG and therefore only 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (40 μg/mL X-gal) was used for blue-white selection. White 
colonies were screened via PCR using pUPD forward and reverse primer (Table 4). The positive 
clones were confirmed by RE digest and sequencing.  
 
Alpha level assembly  
Once the domesticated constructs were successfully confirmed the DNA was mixed with 
appropriate alpha receiver plasmid (Table 5). Reaction mix consisted of 80 ng of the 
domesticated GB patches and 40 ng of the alpha level receiver plasmid, 1 U T4 ligase, 1X T4 
ligase buffer (Thermo Scientific) and water to 10 μL. The cycling parameters for the 
restriction-ligation reaction remained the same as described above. Two microlitres of the 
restriction-ligation reaction mix were used to transform chemically competent E. coli on LB 
agar plates with kanamycin (50 μg/mL) and 40 μg/mL X-gal for blue-white selection. The white 
colonies were confirmed by RE digest using EcoRI and sequencing.  
 
Omega (Final) assembly 
Reaction mix consisted of 80 ng of each assembled gene cassette in their respective alpha 
level vectors and 40 ng of the pDB3-Ω2 level receiver plasmid, 1 μL of BsmBI, 1 μL of T4 ligase, 
1.5 μL of 10x T4 ligase buffer (Thermo Scientific) in final volume of 15 µL. The cycling 
parameters for the restriction-ligation reaction remained the same as described above. Two 
microlitres of the restriction-ligation reaction mix were used to transform chemically 
competent E. coli that were plated on LB agar plates with spectinomycin (50 μg/mL) and 40 
μg/mL X-gal for blue-white selection. White colonies selected were confirmed by RE digest 
using EcoRI and sequencing.  
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Table 5: Layout of the final assembly 
 Alpha level receiver plasmid 
 pDBα11 pDBα12 pDBα13 pDBα14 pDBα2R 
GB-pRIC 4-GFP 
(BeYDV) 









α - IR TAV 2b 
 Alphasatellite -
GFP (BFDV rep) 


















BFDV - IR TAV 2b 
 
Agrobacterium transformation  
Competent A. tumefaciens EHA105 cells were thawed on ice and 1 µL plasmid DNA was added 
to 40 µL of competent EHA105 cells in a 1.5 mL microcentrifuge tube. The tube was frozen in 
liquid nitrogen for about 5 min and thawed at 37 °C. The freeze/thaw cycle was repeated, 0.5 
mL LB was added and incubated at 28°C with shaking for 30-50 min. The cells were pelleted 
in a microcentrifuge for 1 min at maximum speed. Four hundred microlitres of the 
supernatant were removed and the pellet was resuspended in the remaining 100 µL LB. The 
cells were plated onto spectinomycin (50 μg/mL) and rifampicin (50 μg/mL) LB agar plates 
and incubated at 27°C for 2 days. 
 
3.2.2. Gene copy number and replicon formation 
DNA extraction and DNA detection 
Total DNA was extracted from plant tissue using Extract-N-Amp Plant PCR kit (Sigma Aldrich 
USA) as per manufacturer’s instructions. Briefly, one leaf disc was harvested using a 2 mL 
microcentrifuge tube, resuspended in 100 μL extraction buffer and heated for 10 minutes at 




Rolling circle amplification (RCA) 
To confirm the presence of the replicon, rolling circle amplification (RCA) was performed on 
total DNA using a TempliPhi DNA Amplification kit (Amersham Biosciences) as per 
manufacturer’s instructions. RCA utilises the bacteriophage Ф29 DNA polymerase and 
randomly adds hexamers that bind and exponentially amplify ss or ds circular DNA. The RCA 
products were digested with EcoRI and the positive control, pUC19 vector was digested with 
BamHI at 37 °C for 1 h 30 min. The DNA samples were resolved on 1 % agarose gel at 120 V. 
 
Real time quantitative PCR (qPCR) 
DNA was quantified using qPCR performed using the Rotor-Gene RG3000A (Corbett Research, 
Australia) real time PCR machine together with the LuminoCt SYBR Green qPCR ReadyMix 
(Sigma-Aldrich, USA). The reaction was performed in triplicate using 0.1 mL tubes and 
extracted total DNA samples were diluted by a factor of 10. The reaction mixture contained 1 
µL of diluted DNA as a template in a 20 µL reaction, 0.4 µL of 10 µM EGFP internal Fwd and 
Rvs primer (Table 2) and 10 µL LuminoCt SYBR Green qPCR ReadyMix (Sigma-Aldrich, USA). 
pJET 1.2- p35SS-EGFP-pA35SS expression cassette prepared from E.coli cells was used as 
control to construct the standard curve for analysis. Cycling parameters: an initial 
denaturation for 2 minutes at 95 °C was followed by 40 cycles of denaturation for 3 s at 95 °C, 
annealing and extension for 30 s at 60 °C and hold for 5 s at 72 °C. Gene copy number was 
normalized to total plant DNA.   
 
3.2.3. Protein expression 
Protein extraction, assay of EGFP fluorescence and SDS-PAGE and immunoblot analysis were 
done as described in Chapter 2 (See Chapter 2.2.3).  
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3.3. Results  
3.3.1. GoldenBraid assembly proof of concept 
In order to become familiar with the GB cloning technique, the BeYDV plant expression 
vectors pRIC 3.0-GFP (Regnard et al. 2010) and pRIC 4.0-GFP (contains the TAV 2b silencing 
suppressor) were disassembled into standardised GB2.0 parts (Table 6).  
 
Table 6: layout of the BeYDV expression vectors for the GB assembly 
 pDBα11 pDBα12 pDBα13 pDBα14 pDBα2R 
GB-pRIC 3-GFP 
(BeYDV) 









All the domesticated parts and alpha level assembly were confirmed by RE digest and 
sequencing (Data not shown). The final assembly was confirmed using RE digest with EcoRV 
and the correct banding pattern (6674 bp, 2676 bp, 1270 bp) was observed. GB-pRIC 4-GFP 
was digested with EcoRI and only one out of the two selected colonies resulted in the 









































Figure 11: Goldenbraid GB-pRIC 3-GFP and GB-pRIC 4-GFP expression. (A) vector construction confirmation. GB-pRIC 3-GFP 
with EcoRV and the expected band sizes 6674 bp, 2676 bp, 1270 bp. GB-pRIC 4-GFP was digested with EcoRI resulting in the 
expected band size 7533 bp, 3767 bp, 750 bp; (U) Undigested DNA (B) Western blot analysis. N. benthamiana leaves were 
infiltrated with A. tumefaciens at an OD = 0.5. Leaf disc were harvested on day 3, 5, and 7, (+) positive control. Equal volumes 
of the crude extracts were loaded and detected using a rabbit anti-GFP antibody (1:2000). (C) Relative fluorescence units 
(RFU) of the Green fluorescent protein (GFP). Fluorescence reading were observed using the Glomax Multidetection system 
(Promega) at a maximum excitation wavelength of 460 nm and emission wavelength of between 515-580 nm. Each data 
point represents arithmetic mean of triplicates ± SD. A 2Way ANOVA was used to evaluate statistical significance, P values 
represented as, *P<0.05. 
 
GFP expression was determined via immunoblot analysis (Figure 11B) from N. benthamiana 
leaves. Our in-house pRIC 4-GFP was used as a positive control. Detection of the GFP protein 
band (~ 27 kDa) was observed for both constructs with day 3 having a greater band intensity. 
The intensity of the bands increases by day 7 for GB-pRIC 4-GFP construct only, while GB-pRIC 
3-GFP band intensity remained fairly stable. The expression level differences between the two 
constructs were measured using relative fluorescence units (RFU). A higher RFU value was 
achieved when GFP was expressed from GB-pRIC 4-GFP with a 1.9-fold change over days 3 to 





constructs on day 5 but GB-pRIC 3.0-GFP was significantly reduced by day 7 compared to GB-
pRIC 4.0-GFP.  
 
3.3.2. Effects of the BeYDV rep gene on EGFP expression 
It was previously shown that protein expression from the pRIC 3.0-GFP plant vector does not 
correlate with the increase in gene copy number (Regnard et al. 2010). Using the GB 
technique for initial cloning the affect of BeYDV Rep/RepA on protein expression and gene 
copy number of the constructs was determined. The aim was to reduce the gene copy number 
and sequester resources to increase protein expression. BeYDV Rep/RepA protein binds to 
the LIR and initiates replication, resulting in replicon formation from the larger parent plasmid 
(Table 7, highlighted section). N. benthamiana leaves were infiltrated with (1) GB-pRIC 3.0-
GFP (no rep): the vector does not contain the Rep/RepA gene to initiate replication; (2) GB-
pRIC 3.0-GFP, contains all the necessary parts required for replication and (3) GB-pRIC 3.0-
GFP (Rep outside: the Rep/RepA gene is placed on the outside of the replicon) (Table 7).  
 
Table 7: layout of the re-assembled pRIC 3.0 vectors using GB cloning. The rows represent 3 constructs with 
different positions of the BeYDV rep gene. The highlighted section represents the parts required for replicon 
formation. 
 pDBα11 pDBα12 pDBα13 pDBα14 pDBα2R 
GB-pRIC 3.0-GFP 
(no rep) 
Stuffer Stuffer LIR eGFP SIR Stuffer LIR 
GB-pRIC 3.0-GFP  Stuffer Stuffer LIR eGFP SIR Rep/RepA LIR 
GB-pRIC 3.0-GFP 
(Rep outside) 
Rep/RepA Stuffer LIR eGFP SIR Stuffer LIR 
 
 
The plant health was observed for 7 dpi for all the constructs (Figure 12). The plants infiltrated 
with GB-pRIC 3.0-GFP and GB-pRIC 3.0-GFP (Rep outside) displayed mild necrosis 5 dpi and 
deteriorated by day 7. Symptoms of infection in plants infiltrated with GB-pRIC 3.0-GFP (no 
rep) were delayed and mild chlorosis was observed by 7 (Figure 12). Due to the poor heath of 





Figure 12: Effect of Rep gene on leaf morphology. Leaf morphology was monitored from 1 dpi up until 7 dpi and the figure 
shows a comparison between 5 and 7 dpi. 
 
GFP RFU were measured to compare expression levels between the three constructs (Figure 
13).  GFP expression was the greatest when expressed from GB-pRIC 3.0-GFP (Rep outside) 
peaking on day 3. Surprisingly GB-pRIC 3.0-GFP expression levels were similar to GB-pRIC 3.0-








GB-pRIC 3-EGFP (No Rep)
GB-pRIC 3-EGFP
GB-pRIC 3-EGFP (Rep outside)
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Figure 13: Time trial expression of EGFP. Relative fluorescence units (RFU) of EGFP produced in N. benthamiana; GB pRIC 
3-EGFP (no rep), GB pRIC 3-EGFP and GB pRIC 3-EGFP (Rep outside) expression vectors were infiltrated at an OD600 =0.5. 
Leaves were harvested 1, 3 and 5 days post infiltration followed by protein extraction. Fluorescence readings were observed 
using the Glomax Multidetection system (Promega) at a maximum excitation = 460 nm and emission wavelength = 515-
580nm. Each data point represents arithmetic mean of triplicates ± SD. A 2Way ANOVA was used to evaluate statistical 







The BeYDV Rep/RepA protein is responsible for replication, circularization of the replicon. 
DNA copies of GFP using qPCR from all three constructs were compared to determine the 
effect of the Rep/RepA on gene copy number. In general, an increase from 105 to 109 gene 
copy number was observed up until day 3 with a slight decrease by day 5 (Figure 14A). GB-
pRIC 3.0-GFP peaks by day 3 which is comparable with the GFP expression levels observed for 
the same construct in figure 13. The same result was observed for GB-pRIC 3.0-GFP (Rep 
outside) although the expression level was lower compared to GB-pRIC 3.0-GFP (Figure 14A). 
GB-pRIC 3.0-GFP (no rep) copy number remains relatively constant with a decrease by day 5. 
In addition, the presence and formation of the amplicon was confirmed using RCA (Figure 
14B). Absence of any bands for GB-pRIC 3.0-GFP (no rep) confirms that replication did not take 
place and correlates with the fluorescence and gene copy number observed above. The two 
bands observed (1100 bp and 2846 bp) for GB-pRIC 3.0-GFP adds up to the actual size of a 
replicon which is 3946 bp. This coincides with the high gene copy number but does not 
correlate with the low GFP RFU expression. Once again, the opposite is observed for GB-pRIC 
3.0-GFP (Rep outside) where a faint band of ~2700 bp proves the replicon formation took 






























Figure 14: Effect of Rep/RepA on gene copy number and replicon formation. (A) Gene copy number was determined from 
plant extracted DNA using qPCR of GB pRIC 3-EGFP (no rep) (Blue), GB pRIC 3-EGFP (orange) and GB pRIC 3-EGFP (Rep outside) 
(Grey) expression vectors which were infiltrated at an OD600=0.5. Leaves were harvested 1, 3- and 5-days post infiltration 
followed by protein extraction. Error bars represent standard deviation. (B) Electrophoresis gel of RE digested RCA products 
from total plant extracted DNA. The bands indicate the size of the expected BeYDV amplicon over 5 days, (+) pUC19 positive 
control (-) no template control and (M) DNA ladder.  
 
3.3.3. Effect of protein expression using the replication machinery from BFDV and 
alphasatellites. 
Having demonstrated the ease of use and efficiency of the GB technique as well as the effect 
of the BeYDV Rep/RepA protein on protein expression, I wanted to determine whether Reps 
from different viruses would increase protein expression. The objective of this study was to 
design replicating vectors using the replication machinery from BFDV, an avian virus, and 























replication machinery from the above viruses would affect GFP expression in plants and how 
it compares to GB-pRIC 4-GFP.  
 
Goldenbraid construct confirmation 
 
Figure 15: Basic scheme of the GB procedure. Computer screens indicate software-assisted steps. GB parts and TUs can be 
built and stored in a data base. Figure reproduced under the fair-use policy of the University of Cape Town 
 
  
The first step of the GB process was the domestication of all the GB DNA patches to remove 
any internal type IIS RE (BsaI and BsmBI) sites (Figure 15). Successful PCR amplification was 
observed by the presence of the expected fragment size (Figure 16A); alphasatellite Rep 998 
bp, alphasatellite IR 266 bp (Figure 16B), BFDV Rep patch1 775 bp, BFDV Rep patch2 153 bp, 
BFDV IR 202 bp, TAV 2b cassette patch1 1036 and TAV 2b cassette patch2 462 bp. After the 
restriction-ligation reaction using the BsmBI RE all the clones screened for 
pUPD_alphasatellite rep and pUPD_BFDV rep were positive with an amplicon size of 1259 and 
993 bp respectively. Three out of the 4 white colonies screened for pUPD_BFDV IR (463 bp) 
and pUPD_TAV 2b (1760 bp) were positive (Figure 16C). Unfortunately, no colonies were 
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Figure 16: Domestication of the BFDV, alphasatellite DNA parts and the TAV 2b. (A) PCR amplification; (M) Marker; (-): 
negative, no template control; lane 1 alphasatellite rep, lane 2 alphasatellite IR, lane 3 BFDV Rep patch 1, lane 4 BFDV Rep 
patch 2, lane 5 BFDV IR, lane 6 TAV 2b cassette patch 1 and lane 7 TAV 2b cassette patch 2. (B) Successful PCR amplification 
of the alphasatellite IR. (-): negative, no template control and (+) positive control and lane 1) alphasatellite IR. (C) Colony PCR 
screening of white colonies using pUPD primers. (-) negative (No DNA), (+) empty pUPD vector. The expected product size 
was observed for pUPD_alphasatellite rep (1259 bp), pUPD_BFDV Rep (993 bp), pUPD_BFDV IR (463 bp) and pUPD_TAV 2b 
(1760 bp). The PCR amplicons were separated on a 1% agarose gel at 120 V for 1 hr. 
 
The DNA was extracted for two positive clones from each construct and was further 
confirmed using a RE digest with BsaI (Figure 17). The BsaI RE should cut out the insert from 
the pUPD backbone. The expected banding pattern was observed for all 4 constructs 
represented by the red arrows except for colony 1 of pUPD2_alphasatellite-rep. The 
undigested bands which were not subjected to RE digest had the correct band size. The 
constructs were finally confirmed by sequencing and the results agreed with predicted 
sequences on Benchling (https://benchling.com). The DNA concentration ranged from 78.2 
ng/µL to 120 ng/µL (data not shown), this could be the reason for the very faint bands 





Figure 17: Domestication confirmation.  Electrophoresis gel of the Restriction enzyme digest to confirm the domesticated 
constructs using BsaI. The red arrows show the correct band sizes for all the constructs. (M) DNA marker; (U) Undigested 
DNA; pUPD2_alphasatellite-rep= 2105 bp and 964 bp; pUPD2_BFDV-rep = 2105 bp and 868 bp; pUPD2_BFDV-IR = 2105 and 
168 bp; pUPD2_TAV 2b = 2105 bp and 1465 bp. 
 
Alpha level assembly confirmation  
The domesticated GB patches were now ready for the alpha level assembly as described in 
table 7. After the restriction-ligation reaction with BsaI, a RE digest was carried out using EcoRI 
RE and the expected banding pattern was observed for all the alpha level constructs (Figure 
18).  
 
Figure 18: Restriction enzyme digest confirmation of the Alpha level constructs. Digest was carried out with EcoRI RE. All 
the constructs had the correct band sizes with the following fragment sizes; pDBα11-BFDV_IR: 2574 & 206 bp, pDBα14-
BFDV_IR: 2574 & 198 bp, pDBα13-BFDV_rep: 2574, 1120, 994 & 27 bp, pDBα13-alphasatellite_rep: 2574, 1363 & 874 bp, 
pDBα12-GFP_cassette: 2574 & 1994 bp, pDBα2R-TAV 2b_cassette: 7823 & 750 bp. (M): marker and (U): undigested 
 
Since no growth was observed, for the domestication step, the alphasatellite IR was then 
amplified using a new set of primers (Table 4) that contained the BsaI RE site for cloning 
directly into the alpha level vector (pDBα11 and pDBα14) and bypassing the domestication 
step. The alphasatellite IR amplicon was blunt end cloned into pJET 1.2 vector using the 
CloneJET PCR Cloning Kit (Thermo Scientific). Ten positive colonies were screened using pJET 
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specific primers and a 398 bp product was observed for 7 colonies (Figure 19A). Colonies 2, 9 
and 10 were selected and digested with BsaI which successfully cuts out the 237 bp IR, 
represented by the black arrow (Figure 19B). The pJET-alphasatellite IR was added to the 
restriction-ligation reaction with BsaI to clone it into the alpha level vectors, pDBα11 and 
pDBα14. A few white colonies grew on the pDBα14 plate and 5 were selected for RE digest 
with BsmBI (Figure 19C).  Unfortunately, the expected banding pattern was not observed and 
thus the alphasatellite IR was yet to be cloned into pUPD.  
 
Figure 19: Confirmation of pJET 1.2_alphasatellite IR and alphasatellite IR in pDBα14. (A) Colony PCR of the positive clones 
using pJET primers, (M): marker, (-ve): No DNA template control. (B) Restriction enzyme digest confirmation of pJET 
1.2_alphasatellite IR colonies using BsaI. The expected banding sizes 2625, 380 & 237 bp (U): undigested DNA. (C) RE digest 
of the pDBα14_alphasatellite IR, unfortunately the expected band size, 2596 & 241 bp, was not observed  
 
Final assembly confirmation  
The final step was to place all the alpha level assemblies with the final entry vector pDB3-Ω2 
for the last restriction-ligation reaction.  Since the alphasatellite IR was not domesticated nor 
cloned into the alpha level vectors, I was unable to construct the alphasatellite vectors as 
described in table 5. I attempted to construct the BFDV vectors with GFP expression cassette, 
GB-BFDV-GFP, as well as the BFDV vector with the alphasatellite rep gene, GB-BFDV-GFP 
(alphasatellite) (Table 5). For the assembly of GB-BFDV-GFP vector, 17 colonies were observed 
after growth on spectinomycin plates. Unfortunately, after multiple attempts no growth took 
place after inoculation into LB media. A different version of the final entry vector was then 





efficiency than the original pDB3-Ω2. After transformation with the pDB1-Ω1-BFDV-GFP 
construct, only 16 white colonies and a ~120 blue colonies were observed. Two of the white 
colonies were digested with EcoRI (Figure 20). The bands observed were not of the expected 
sizes and seems to be the size of the empty pDB1-Ω1 (~3000 bp). The same results were 
observed for the GB-BFDV-GFP (alphasatellite rep) vector. However, the pDB3-Ω2 entry 
vector was used in this case and 24 white colonies had grown with only 2 blue colonies. After 
RE digestion the bands represented by the white arrows adds up to the size of an empty pDB3-
Ω2 vector, 7295 bp (Figure 20).  
 
Figure 20: Gel electrophoresis of the RE digest of GB-BFDV-GFP (alphasatellite) and GB-BFDV-GFP vectors. (M) 


















Expression systems based on plant viruses have become one of the most useful tools in 
molecular biology (Hefferon & Fan 2004; Zhang & Mason 2006; Huang et al. 2009; Regnard et 
al. 2010). Geminiviruses are among the viral vectors tested as an expression platform. Their 
replication features makes them particularly useful to increase the gene copy number and 
expression of foreign proteins (Regnard et al. 2010;  Palmer & Rybicki 1997; Hayes et al. 1989). 
Regnard et al. (2010) showed high level of protein expression from the replicating vector, pRIC 
3.0 compared to its non-replicating counterpart. However, gene copy number was still 100x-
1000x greater than the protein expression levels that only increased 1.5-7 fold even in the 
presence of a pBIN-NSs silencing suppressor protein (Regnard et al. 2010).  In this study I 
aimed to improve expression based on the replication machinery of the BeYDV and other 
replicating viruses (BFDV and alphasatellites). To ease the designing and production of the 
replicating vectors, the GB technology was used to standardise the pRIC 3.0 replicating parts.  
The GB assembly technology incorporates these features through the standardisation of DNA 
sequences or parts to form multi complex constructs (Sarrion-Perdigones et al. 2013; Sarrion-
Perdigones et al. 2011). To prove the efficiency and ease of this technique, the pRIC 3.0 vector 
was disassembled into standard DNA parts and re-constructed into GB-pRIC 3.0-GFP and GB-
pRIC 4.0 (TAV 2b). The constructs were successfully confirmed (Figure 11A) and a high level 
of GFP expression was observed 5 dpi (Figure 11C). This entire expression system took 
approximately 8-9 days to assemble and verify. This might seem time consuming but once all 
the parts are set up in the databases, multiple constructs can be assembled and verified within 
one week. The assembly, in particular, is faster than BioBricks (Knight 2003). The binary 
assembly of BioBricks allows only two DNA pieces to be flanked by a set of restriction sites 
and assembled together to form one part. This slows down the process when trying to 
assemble multiple parts (Knight 2003; Sarrion-Perdigones et al. 2011). Overall, I showed that 
DNA parts can be standardized and efficiently assembled into replicating plant expression 
vectors. 
Plant virus expression systems have been used for efficient expression of heterologous 
proteins (Gleba et al. 2007). Specific interest has been given to replicating vectors based on 
geminiviruses. Here I tried to explore the use of the replication machinery from 
alphasatellites, and the avian virus BFDV. Both viruses replicate with aid of the Rep protein, 
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via RCR (Cheung 2015; Nawaz-ul-Rehman & Fauquet 2009). To achieve this the GB technique 
was used to try and assemble these replicating vectors. The rep genes as well as their IR were 
successfully amplified and cloned into the domesticator pUPD plasmid (Figure 17). These 
parts have now been standardised and placed into a data base for future use. Due to the close 
similarities of the BFDV and alphasatellites replication component, I anticipated that I would 
be able to observe significant effect on protein expression. The alphasatellite IR could not be 
domesticated and it was suggested to directly clone it into the alpha level entry vectors, 
however this was also unsuccessful. The 266 bp DNA fragment was blunt end cloned into pJET 
1.2 and was confirmed using PCR and RE digest and therefore cannot be toxic, since it was 
maintained in E. coli. The problem appears to emerge when cloning into the GB entry vectors. 
This will need further investigation since all the nt overhangs were confirmed to be correct. 
The rest of the parts were assembled in their relative alpha level vector and were successfully 
confirmed. However, the final assemblies were not successful (Figure 20). Based on 
observation, after transformation one can tell by the number of colonies whether the reaction 
was successful. Many white colonies with few blue colonies indicate a successful clone. Equal 
amounts of white and blue colonies suggest that too much of destination plasmid was present 
and/or that the RE did not work well. No or only a handful of colonies means that either one 
of the parts were missing in the assembly reaction or was considerably under-represented. In 
this case very few white colonies were observed compared to the blue colonies. On plates 
where white colonies were observed, it would be worthwhile to screen more or all of the 
white colonies or design primers that would amplify different parts of the final construct. This 
would ensure that all the parts have been ligated. Furthermore, BsmBI enzymes have an 
optimal temperature of 37 °C (Alonso and Stepanova 2015). Enzymes from different suppliers 
have different optimal incubation temperatures affecting the efficiency of the restriction–
ligation reactions. An increase above 37 °C would affect T4 ligase activity and stability. 
Example the BsmBI enzyme used in this study was from Fermentas (Thermo Scientific) and 
has temperature optimum of 37 °C but needs high dithiothreitol (DTT) concentration in the 
buffer. On the other hand, BsmBI from New England biolabs (NEB) has a temperature 
optimum 55 °C but does not need the DTT. In addition, frequent freezing and thawing cycles 
reduces the efficiency of BsmBI reactions. In future work, increasing the DTT concentration 
would be an important step to ensure the efficiency of the enzyme as well as making 10 µL 
aliquots of the RE. Since DNA stock of each part are stored at -20 °C in a database, it would 
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be best to first confirm that the concentration of the DNA is correct by quantifying it or 
viewing it on an agarose gel. Perhaps it would be best to extract DNA from fresh colonies that 
were streaked from a glycerol stock.  
Furthermore, I exploited the use of the multifunctional Rep/RepA protein from the BeYDV 
based vector, pRIC 3.0, to try and increase protein expression. The Rep/RepA protein aids 
replication which increases the gene copy number and enhances protein expression within 
the vector based replicons (Regnard et al. 2010). To further improve protein expression from 
pRIC, it was suspected that regulating replication by placing the rep gene on the outside of 
the replicon, may be required to increase protein expression. BeYDV replication has been 
shown to be highly efficient and may divert resources away from protein translation (Palmer 
& Rybicki 1997; Regnard et al. 2017). DNA replicons are particularly useful because they 
replicate in the nucleus using host factors to aid replication and can house large foreign 
inserts. Here I show that the Rep/RepA protein had a significant effect on the plant 
morphology and GFP expression (Figure 13). GB-pRIC 3.0-GFP (no rep) had a similar 
fluorescence value as GB-pRIC 3.0-GFP (Figure 13) but GB-pRIC 3.0-GFP achieved the highest 
gene copy of 109 while GB-pRIC 3.0-GFP (no rep) was significantly lower (Figure 14A). The GFP 
fluorescence results are contrary to what was demonstrated by Regnard et al. (2010) where 
the pRIC 3.0-GFP vector had a significant increase in protein expression compared to its non-
replicating counterpart, pTRAc. In addition, the EGFP copy number increased from 106 to 109 
copies 3 days post inoculation when expressed from pRIC 3.0-GFP which corresponds with 
the results obtained for the GB-pRIC 3.0-GFP. Interestingly, a noticeable improvement of GFP 
expression was achieved when using the GB-pRIC 3.0-GFP (Rep outside) vector which had the 
greatest RFU even though the rep/repA was placed on the outside of the replicon. The gene 
copy number was also significantly high even though the RCA results were less conclusive 
(Figure 14B). This is in line with other findings where the Rep/repA was placed in trans. Mor 
et al. (2003) demonstrated that BeYDV-derived vector co-delivered by bombardment with a 
Rep/RepA-supplying vector greatly enhanced GFP expression and resulted in replicon 
formation. Moreover, a previous study demonstrated that co-infiltration of the Rep- 
supplying vector and a replicon vector resulted in enhanced EGFP expression with the 
addition of p19 post translational silencing suppressor (Huang et al. 2009). The increase in 
GFP expression from the GB-pRIC 3.0-GFP (no rep) could be due to the cowpea mosaic virus 
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(CPMV) expression cassette. The pRIC vectors contain a cauliflower mosaic virus (CaMV) 
expression cassette. A previous study found  increased protein accumulation as well as self-
assembled virus like particles (VLPs) in the absence of the replication function of a disabled 
version of the Cowpea mosaic virus RNA-2 (Sainsbury & Lomonossoff 2008). Geminiviral 
promoters appear to be tightly regulated depending on the stage of viral life cycle (Palmer & 
Rybicki 1997). It would be worthwhile to investigate RNA levels to determine which step, 
replication or translation, leads to the decrease in protein expression. These possibilities are 
the subject of ongoing research. 
Plants have an innate ability to induce a hypersensitive response (HR) in the presence of a 
pathogen attack (Greenberg, 1997; Van Wezel et al. 2002). The HR restricts multiplication and 
systemic spread of the pathogen. The decrease in gene copy number and GFP fluorescence 
also coincides with onset of leaf necrosis and chlorosis. A significant amount of necrosis and 
chlorosis of the leaves was observed in the presence of the Rep/RepA protein whereas in its 
absence the symptoms were significantly delayed (Figure 12). In addition, Van Wezel et al., 
(2002) were able to demonstrate that the presence of the Rep from two begomoviruses, the 
African cassava mosaic virus (ACMV) and the Tomato yellow leaf curl virus-China, triggered 
an HR. This infers that the replication machinery of the BeYDV based vectors can affect the 
leaf morphology which seems to have affected the protein expression levels (Figure 13). 
Pathogens have a counter defence which makes use of certain proteins that act as 
suppressors of post transcriptional gene silencing (PTGS) (Voinnet et al. 1999). The addition 
or co-expression with a silencing suppressor such as the P19 protein of TBSV has been shown 
to reduce PTGS and improve protein yields (Peyret & Lomonossoff 2015).  
In conclusion, I was able to show that the GB cloning technology could be useful for 
disassembling and reassembling DNA parts; however, this was not the case when using DNA 
parts that were not in the data base. In addition, we were able to show that BeYDV Rep 
protein had a significant effect on protein expression depending on where it was placed 






Chapter 4: Testing of Zika virus PrME-His expression by the optimized 
expression vectors 
4.1. Introduction 
Zika virus (ZIKV) is a vector borne pathogen that was first isolated in 1947 from rhesus 
macaque monkeys in the Zika forest of Uganda. Recent outbreaks of Zika fever in Latin 
America, however, made it an emerging infectious disease (Calvet et al. 2016). Prior to this 
the virus had remained relatively dormant with only a few cases reported before 2007. 
Transmission of the virus is via the Aedes aegypti mosquito and the first major outbreak 
occurred in Yap (Federated states of Micronesia) in 2007, when approximately 75 % of the 
population was infected (Duffy et al. 2009). Since then ZIKV has spread sporadically to French 
Polynesia (2013-2014) (Hancock et al. 2014), the Cook Islands, Easter Islands, New Caledonia, 
and most recently the Latin Americas (Plourde & Bloch 2016). By June 2017, the World Health 
Organization reported that 85 countries have reported mosquito-borne Zika virus 
transmissions. This created a challenge particularly in areas where those infections co-
circulate with dengue and other febrile-illnesses and has resulted in a heavy burden on health 
systems.  
Virology and epidemiology 
The virus belongs to Flaviviridae family and falls under the Flavivirus genus which includes 
other clinically important arboviruses such as dengue (DENV), Japanese encephalitis virus 
(JEV) and West Nile virus (WNV) (Lanciotti et al. 2008). In addition, the virus originated from 
two distinct African and Asian lineages as determined by phylogenetics, and is closely related 
to the only other member of its clade, Spondweni virus (Plourde & Bloch 2016). The Zika virion 
is an enveloped icosahedron and contains a non-segmented, single-stranded, positive sense 
RNA genome. The genome encodes for three structural proteins, the capsid (C), pre-
membrane (Pr), membrane (M) and an envelope (E) protein and seven non-structural 
proteins  (Baronti et al. 2014). The E protein consists of 3 domains (I, II and III), is responsible 
for virus entry and attachment, and is a major target for neutralizing antibodies (Dai et al. 
2016). The virus enters the host cell via endocytosis which results in particle disassembly due 




Figure 21: Flavivirus life cycle (virologie.meduniwien.ac.at). Figure reproduced under the fair-use policy of the 
University of Cape Town 
 
This causes the E protein to undergo an irreversible conformational change from a dimer to a 
trimer due to the acidic endosomal environment (Modis et al. 2004). The genome is released 
into the cytoplasm and the positive sense RNA is translated into a single polyprotein. The 
polyprotein is then processed by viral and host proteases (Allison et al. 1995; Lindenbach & 
Rice 2007). Viral assembly takes place in the endoplasmic reticulum (ER), forming immature 
virions that contain 60 spiky heterotrimeric protrusions of E and PrM arranged in icosahedral 
formation (Figure 22) (Zhang et al. 2003; Dai et al. 2016; Mukherjee et al. 2016). At this stage 
the immature virions are considered non-infectious since the E protein cannot undergo 
conformational change required for viral fusion (Zybert et al. 2008). Virus maturation occurs 
in a low pH environment as the immature virions travel through the trans-Golgi network 
(TGN). The low pH induces a structural change of the PrME heterodimer into homodimer 
which also exposes the furin protease recognition site. The host cell furin protease cleaves 
the PrM, releasing the M protein and a soluble Pr protein. Cleavage of PrM is an important 
event in flavivirus maturation and essential step in the infectious life cycle (Elshuber et al. 
2003). The PrM protein acts as a chaperone for correct folding of E protein (Lorenz et al. 
2002). The M protein consists of a short extracellular domain attached to the membrane via 
two extracellular transmembrane α-helices and remains associated with the virion even after 
cleavage. M gets buried by the ectodomain of E protein, resulting in rare antibody responses 
against the M protein (Setoh et al. 2011; Davis et al. 2001; Darwish & Khor 2016; Chavez et 
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al. 2010). The E protein is the focus for the development of neutralizing antibodies, which 
have been found to mainly target domain III. The type-specific neutralizing epitopes are 
located in the upper lateral surface of domain III and the peptides are considered a potential 
candidate for vaccine development. Studies also show that fewer cross-reactive epitopes are 
found in domain III compared to I and II of the E protein (Beltramello et al. 2010; Chavez et 
al. 2010). 
 
Figure 22: Structure of Flavivirus. (A) The virus consists of the envelope (E) protein (yellow), membrane (M) protein (orange) 
and capsid (C) protein (green). (B) The cryo-EM structure of the mature ZIKV at near atomic resolution (3.8Å). A cross-section 
of ZIKV showing the radial density distribution. The protein and RNA core (dark blue) contacts the inner layer of the viral 
membrane (aqua) and the surface proteins (red, yellow and green). Adapted from viralzone.expasy.org and (Sirohi et al. 
2016) . Figure reproduced under the fair-use policy of the University of Cape Town 
 
Diagnoses, Treatment and control 
The incubation period of ZIKV in humans is approximately one week; however, infection in 
many cases is asymptomatic (Ioos et al. 2014). Symptoms occur about two to seven days after 
the mosquito bite, which is similar to dengue fever. Symptoms consist of mild fever, rash and 
headaches, myalgia, arthralgia and conjunctivitis (Duffy et al. 2009). Zika virus is also possibly 
associated with congenital microcephaly and Guillain–Barré syndrome. This has been 
confirmed with the detection of virus RNA in the amniotic fluid and brain tissue of foetuses 
with microcephaly (Powers et al. 2016). 
During the acute phase of the illness viral nucleic acids can be detected using reverse 
transcription PCR (RT-PCR) (Plourde & Bloch 2016). Immunoglobulin M (IgM) antibodies are 
detected by IgM-capture enzyme-linked immunosorbent assay (MAC-ELISA). Unfortunately, 
anti-Zika virus IgM and IgG are often cross-reactive with other flaviviruses (and particularly 
DENV) thus, the specificity of serologic tests is limited.  
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There are currently no vaccines available against ZIKV infection. However, there are a few 
ZIKV vaccine platforms that are currently being developed as vaccine candidates: DNA based 
vaccines (NIAID), purified inactivated virus, plasmid-based DNA vaccine and a recombinant 
rhesus adenovirus serotype 52 vector that expresses the ZIKV PrME. The vaccines elicited 
neutralizing antibodies and completely protected monkeys against ZIKV challenge (Abbink et 
al. 2017). In addition, messenger RNA (mRNA) based vaccines that were tested in animals 
include a nucleoside-modified mRNA vaccine that is formulated with lipid nanoparticles (Pardi 
et al. 2017). Although these candidates look promising, the safety and cost associated with 
the vaccines still needs to be addressed before they can become viable. A recent study 
successfully demonstrated the production of plant-produced virus-like particles (VLPs) based 
on the hepatitis B virus core antigen (HBcAg) that displays ZIKV Domain III (DIII). The HBcAg-
zDIII VLPs provided a protective immunity in mice against other Zika strains and did not 
enhance dengue virus infection (Yang et al. 2017a; Yang et al. 2017b). 
 
In this study, I attempted to express the pre-membrane (PrM) and enveloped (E) protein with 
a His tag, using two plant expression vectors. The aim was to express the ZIKV-PrME gene in 
N. benthamiana from different plant expression vectors to determine vector efficacy and 
produce plant-made ZIKV VLPs.  
 
4.2. Material and methods:  
4.2.1. Construction of vectors    
Gene synthesis 
The PrME gene sequence was assembled as a consensus through multiple sequence 
alignment and then synthesized by GenScript® (China) so as to include restriction sites for 
cloning into the plant expression vectors (Figure 23A). The gene was also codon-optimized for 






Cloning into pEAQ-HT and pRIC 4.0 
The gene was successfully cloned into the two plant expression vectors pRIC 4.0 (a 
geminivirus-derived replicating vector) and pEAQ-HT (Sainsbury et al. 2009), which contains 
a hyper-translatable element (Figure 23B). A 6x histidine tag sequence was added to the C-
terminal end of the E gene using high-fidelity PCR. The PrME sense primer contained the AgeI 
and BspHI for cloning into pEAQ-HT and pRIC 4.0 respectively (Table 8). The 6x histidine tag 
and XhoI site were added using two antisense primers, PrME 3 his R and PrME 3 his XhoI R. 
The first high-fidelity PCR 50 µL had final concentrations of 1x Phusion GC buffer, 200 µM 
dNTP’s, 0.02 U/µL Phusion DNA polymerase (Thermo Scientific™ (USA)), 0.5 µM PrME sense 
primer and 0.5 µM PrME 3 his antisense primer (Table 8) and 1 ng/µL of pEAQ-PrME template 
DNA. The primers amplified a 2024 bp DNA product encompassing the PrME gene and 
incorporating 3 histidine codons. The thermocycling was performed using a MyCycler™ 
thermal cycler (Bio-Rad) and the parameters were as follows: an initial denaturation cycle for 
30 s at 98 °C was followed by 30 cycles of denaturation for 10 s at 98 °C, 30 s at an annealing 
temperature of 56 °C, extension for 60 s at 72 °C and a final cycle comprising of an extension 
at 72 °C for 300 s. The PCR product was resolved on TBE agarose gel containing 2.5 mg/mL 
ethidium bromide and visualised under long-wavelength UV light (360 nm). The PCR product 
was excised under long-wavelength UV light and gel purified using the QIAquick® Gel 
Extraction kit (Qiagen, Netherlands) as per manufacturer’s instructions. The purified PCR 
product was used as a template for a PCR to include the final histidine codons and restriction 
enzyme site (Table 8). The reaction conditions were kept the same as described above except 
0.5 µM PrME 3 His XhoI reverse primer (Table 8) was used. The PCR product was purified as 
described above. All restriction enzymes used in this study were obtained from Thermo 
Scientific and New England biolabs (NEB). The vector DNA, pEAQ-HT and pRIC 4.0, was 
extracted using the GeneJET Plasmid Mini-prep Kit (Thermo Scientific) as per manufacturer’s 
instructions. The vector DNA was linearised with AflIII/XhoI (pRIC 4.0) and with AgeI/XhoI 
(pEAQ-HT) for 1 hour at 37 °C. The DNA fragments were purified as described above.  
The purified PrME-6x His PCR product was digested with either AgeI/XhoI or BspHI/XhoI for 
cloning into pEAQ-HT and pRIC 4.0 respectively. After incubation for 1 hour at 37 °C, the DNA 
fragments were gel purified as described above. DNA ligation was performed using T4 DNA 
ligase from the Quick Ligation™ kit protocol (BioLabs® Inc.) with a 1:3 ratio of vector to insert 
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in final volume of 20 μL. The mixture was incubated at room temperature for 5 minutes as 
per manufacturer’s instructions. 
 
Table 8: Primers used for PCR and qPCR 









PrME 3 His 
R 
5´atggtgatgAGCTGAAACAGCAGTAGAAAGAAA 3´ 60 
















pTRA-FP 5´CATTTCATTTGGAGAGGACACG 3´ 64 Used for 
sequencing 
pTRA-RVS 5´GAACTACTCACACATTATTCTGG 3´ 64 
pEAQ-HT F 5´TTCTTCTTCTTGCTGATT GG 3´ 56 
pEAQ-HT R 5´CACAGAAAACCGCTCACC 3´ 56 
Primers were designed using the CLC Main Workbench 6 (QIAGEN Bioinformatics) and synthesised by the DNA 
Synthesis Unit (MCB, UCT). 
 
Escherichia coli preparation and transformation 
Escherichia coli preparation and transformation of DNA were done as described in Chapter 2 
(See Chapter 2.2.1).  
 
Screening of positive clones 
Putative positive clones were screened using colony PCR in a final volume of 40 μL. The final 
reaction concentrations were 10 μM of PrME Int Fwd primer and the PrME Int Rvs primer (Table 
8), 1.5 mM MgCl2, 1x GoTaq® Reaction Buffer, 0.2 mM dNTP and 1.25 U GoTaq® DNA polymerase 
(Promega, USA). The primers were designed to amplify an 890 bp DNA product encompassing the 
PrME gene. The thermocycling parameters using the MyCycler™ thermal cycler (Bio-Rad): an 
initial denaturation cycle for 2 minutes at 95 °C was followed by 30 cycles of denaturation for 30 
s at 95 °C, 30 s at an annealing temperature of 51 °C, extension for 54 s at 72 °C and a final cycle 
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comprising of an extension at 72 °C for 2 minutes. The PCR products were visualized on a 1 % 
agarose gel to determine the positive colonies. The positive colonies were picked from the agar 
plate and inoculated in 10 mL LB with appropriate antibiotics. The plasmid DNA was extracted 
using the GeneJET Plasmid Mini-prep Kit (Thermo Scientific) as per manufacturer’s instructions 
followed by quantification using a Nanodrop (Thermo Scientific™). Restriction enzyme digest 
with EcoRV/XhoI, BspHI, AgeI/XhoI and PstI for 1 hour at 37 °C was carried out to confirm the 
fragment sizes of the construct and resolved by gel electrophoresis on 1% TBE agarose gel. Clones 
were further confirmed by sequencing analysis (Macrogen Inc.) using pTRA fwd and pTRA Rvs 
primers (Table 8) for pRIC 4.0-PrME- His and pEAQ-HT Fwd and pEAQ-HT Rvs for pEAQ-PrME- His. 




Agrobacterium tumefaciens preparation and transformation and back transformation were 




Figure 23: The region of the ZIKV polypeptide and final constructs used for the expression in N. benthamiana. (A) A 
consensus sequence of the PrME region was codon-optimised and synthesized by GenScript. A 6x His tag sequence was 
incorporated at the C-terminal end of the E gene. (B) The PrME 6× His gene was cloned into pEAQ-HT and pRIC 4.0 using AgeI 
and BspHI respectively on the 5’ end and XhoI on the 3’ end. LIR, BeYDV long intergenic region; SIR, BeYDV short intergenic 
region; Rep/RepA, BeYDV replication associated gene; 3´NTR, non-translated region. (Regnard et al. 2010; Sainsbury et al. 
2009; viralzone.expasy.org) 
 
4.2.2. Infiltration into N. benthamiana 





4.2.3. Protein expression 
Total protein was extracted for small scale expression studies. Briefly, three leaf discs were 
harvested using the top of a 2 mL microcentrifuge tube. Two ceramic beads (Biogen) and 250 
μL per leaf disc of one of the following buffers: 1X phosphate buffered saline (PBS), General 
lysis buffer, 8M urea extraction buffer, acidic extraction buffer (Yang et al. 2017a) or 100 mM 
Tris-HCl (Table 9). Some of the buffers included the CompleteTM, EDTA-free protease inhibitor 
(Roche Diagnostics) as per manufacturer’s instructions. The samples were vortexed at 
maximum speed for 10 min and centrifuged at 15871 x g (13000 rpm) for 5 minutes. The 
supernatant was transferred to a 2 mL microcentrifuge tube and centrifuged at 15871 x g 
(13000 rpm) for 5 minutes. The previous step repeated and the clarified samples were stored 
at -20 °C prior to protein analysis. 
Table 9: Different protein extraction buffers used for PrME extraction from N. benthamiana leaves  
Name  Ingredients   Protease inhibitor  
PBS extraction buffer 1X phosphate buffered saline (PBS) CompleteTM, EDTA-free protease 
inhibitor 
General lysis buffer 50 mM Tris-HCl pH =7.5, 100 mM 
NaCl, 1 mM DTT, 5% glycerol 
CompleteTM, EDTA-free protease 
inhibitor 
Urea extraction buffer 300 mM NaCl, 50 mM Tris (pH 7.6), 
1 M DTT and 8 M Urea 
 
Acidic buffer 1 mM EDTA & 1 x PBS pH 5.2  
Tris-HCl extraction buffer  100 mM Tris-HCl (pH 7.6), 1% 
TritonX-100   
 
 
SDS-PAGE and immunoblot analysis 
Samples were prepared by adding 5x SDS sample application buffer (2% SDS, 100 mM Tris-
HCl, pH 7.5, 2 mM EDTA, 52% glycerol, 4.3% β-mercaptoethanol, 0.25% bromophenol blue) 
to a final concentration of 1x and heated at 90 °C for 3 minutes. Equal volumes of the sample 
were resolved on a 12.5% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) at 20 mA for approximately 90 minutes. The SDS gel was transferred onto a 
nitrocellulose membrane by semi-dry blotting using a Bio-Rad Trans-Blot® Semi-dry transfer 
cell for 1 hour at 15 V. The membrane was then blocked with blocking buffer (1 x PBS, 2% 
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Bovine serum albumin (BSA), 1% tween-20) and incubated at room temperature for 30 min 
with gentle shaking. The membrane was then incubated with 1:2000 dilution of anti-His-tag 
mouse IgG antibody (Bio-Rad) diluted in blocking buffer, was added to the membrane and 
probed for 2-4 hours at room temperature at 4 °C with gentle shaking. Thereafter the 
membrane underwent four 15 minute washes in blocking buffer with shaking followed by 
incubation with a 1:2000 dilution of anti-mouse secondary antibody conjugated to alkaline 
phosphatase (Sigma-Aldrich®) for 2-4 hrs at room temperature. All the above steps were 
performed with gentle shaking in blocking buffer without milk. The 6× His-labeled protein 
were visualised with 3-5 mL NBT/BCIP (Roche, Switzerland) solution for 1 hour or until protein 
bands appeared after which the reaction was stopped using water. 
 
4.3. Results 
4.3.1. Vector construction of pRIC 4-PrME- His and pEAQ-PrME- His 
The successful cloning of the pRIC 4-PrME-His and pEAQ-PrME-His final constructs was 
confirmed using colony PCR. Positive clones would result in a PCR product of 890 bp and this 
band size was observed for the positive control as well (Figure 24A). As expected, there were 
no bands observed for the negative (no template) control. Colonies that contained empty 
plasmid would not produce any bands because internal PrME primers were used. All clones 
tested positive with one positive clone selected for each construct and confirmed by 
restriction enzyme digest. The correct banding pattern was observed for both constructs; 
undigested pRIC 4.0-PrME- His had a band of approximately 9382 bp and when digested with 
BspHI resulted in three bands, 1012 bp, 3179 bp and 5203 (Figure 24B). pEAQ-PrME- His   
when digested with XhoI/AgeI resulted in 9953 bp and 2043 bp bands, the latter being the 
PrME- His gene. The constructs were then further confirmed by sequencing. The sequencing 
results agreed with predicted sequences on CLC Main Workbench 6. The vectors were 
successfully electroporated into A. tumefaciens cells. A back transformation was performed 




Figure 24: Confirmation of construction. (A) Colony PCR of the recombinant clones using internal PrME primers with an 
expected product size of 890 bp. Positive control (+) and negative control (-).  (B) Restriction enzyme digest confirmation of 
the pRIC 4-PrME- His and pEAQ-PrME- His. The Following DNA sizes was observed: pRIC 4.0-PrME- His EcoRV/XhoI 339 bp, 
773 bp, 1073 bp and 7201 bp; BspHI 1012 bp, 3179 bp and 5203 bp. pEAQ-PrME- His, PstI 2515 bp, 4407 bp, 5078 bp, 
XhoI/AgeI 2043 bp and 9953 bp.  
      
4.3.2. Transient expression in N. benthamiana and comparison of extraction buffers 
A small-scale expression time trial was carried out to determine the optimal optical density 
(OD600) for the highest expression, and the plant health was observed. The positive control 
was a Rift Valley fever virus (RVFV) nucleocapsid (N) protein that has been shown to express 
well in plants: these became necrotic on day 9, and leaves infiltrated with pRIC -PrME-HIS also 
turned yellow on day 9 (Figure 25). Plants infiltrated with pEAQ-PrME-His remained healthy 







Figure 25: Effect of the ZIKV-PrME-HIS expression on leaf morphology of N. benthamiana. Leaf morphology was 
monitored from 1 dpi up until 9 dpi and the figure shows a comparison between 5 and 9 dpi. The positive control was a 
RVFV nucleocapsid (N) protein.  
 
In order to obtain the correct protein size, one needs to determine the best extraction buffer 
that will produce the desired protein. Since PrME was still novel to plant expression, different 
protein extraction buffers were tested to obtain the predicted protein size of approximately 
75 kDa (Table 9). Initially TSP was extracted using 1x PBS but no specific proteins were 
detected during immunoblotting. This was repeated using a Tris-HCL extraction buffer and 
only the positive control of 25 kDa band was detected (Figure 26A). Since the protein was still 
undetectable an acidic extraction buffer was then used to remove RuBisCo (a plant 
contaminating protein). Unfortunately, the 74 kDa PrME-HIS protein was not detected from 
any of the above extractions buffer. It was then decided to try a general lysis buffer and to 
test the solubility of the protein with the addition of 8 M urea. Both the pellet and supernatant 
were loaded onto the gel but no band was observed (Figure 26 B). 
 
Figure 26: Western blot analysis for expression buffer comparison. Small scale expression of pEAQ-PrME followed by 
protein extraction. (A) Tris-HCL + 1 % TritonX-100. 1: pEAQ-PrME-HIS, +: positive control (pEAQ-N-His) (B) Urea, PBS and 






Different platforms have been used to make ZIKV vaccine candidates. These platforms include 
plasmid DNA vaccines, inactivated viruses, modified mRNA encapsulated by nanoparticles 
and adenovirus vaccines (Pardi et al. 2017; Abbink et al. 2017). The above candidates also 
show promising protection in mice and Rhesus macaque monkeys. However, these platforms 
present multiple problems such as scalability, high downstream cost and risk of not 
inactivating live viruses. Yang et al. (2017a) recently developed a subunit vaccine based on 
the E protein that was successfully expressed in plants and conferred immunogenicity in 
animals. A 6x His tag was added to both the N- terminus and C-terminus of the ZIKV E protein 
DNA coding sequence and then cloned into the TMV-based expression vector of the 
MagnICON system. A range of monoclonal antibodies that recognize various E conformational 
epitopes were able to bind to the plant produced ZIKV E. In addition, ELISA results showed 
that ZIKV E accumulated to >160 µg per gram of leaf fresh weight (LFW) 6 days post 
agroinfiltration (DPI). Furthermore, the group also designed a virus-like particle (VLP) carrier 
based on the HBcAg that displays the domain III of ZIKV E protein. The results showed that it 
could be easily and quickly produced and purified in large quantities (Yang et al. 2017a).  
In order to test the efficacy of our in-house vector pRIC 4.0, I aimed to clone the PrME gene 
with a His tag into this vector and to optimize PrME expression. In addition, the PrME- His 
gene was cloned into the pEAQ-HT to compare which vector had the higher protein 
expression levels. The PrME-His gene was successfully cloned into pRIC 4.0 and pEAQ-HT and 
was further confirmed by sequencing (Macrogen). Unfortunately, the PrME-His protein was 
undetectable on a western blot using anti-His antibody. The same result was observed for all 
the different protein extraction buffers. Furthermore, the correct use of controls confirmed 
that the lack of expression observed for the ZIKV protein in plants was protein related. 
The lack of protein expression could be explained by the fact that virus assembly takes place 
in the ER to form immature, non-infectious virions  (Zybert et al. 2008; Mukherjee et al. 2016). 
Targeting proteins to the ER improves protein yields, allows for glycosylation if need be  and 
prevents proteolytic degradation by retaining the protein in the ER (Schouten et al. 1996; 
Stoger et al. 2014). It has been shown that adding a retention sequence to C-terminal end of 
the E protein will allow for translocation to the ER and in turn viral assembly. On the contrary, 
the PrME gene used in this study does not include the native signal peptide which is found on 
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the C terminal end of flavivirus C protein. The hydrophobic signal sequence anchors the C 
terminal end to the ER membrane which allows the Pr and M protein to be translocated into 
the ER (Qi et al. 2008). Martinez et al., (2011) successfully demonstrated expression of dengue 
virus E protein with an ER retention sequence in N. tabacum and Morinda citrifolia. The 
expression cassette consisted of a signal peptide at the N-terminus and an ER 
retention/retrieval sequence, KDEL (Lys-Asp-Glu-Leu) was added to the C-terminus. The 
CPrME (capsid, premembrane and envelope) expressed with a KDEL sequence had higher 
accumulation levels than the constructs without (Martínez et al. 2011). This would be useful 
strategy to increase expression levels of the ZIKV PrME-His used in this study.  
Another alternative would be to co-express the PrME protein with furin protease. Furin is a 
human protease responsible for proteolytic cleavage of PrM into soluble Pr and M proteins 
which is a crucial step for maturation and infection. Elshuber et al., (2003) showed that furin 
protease cleavage of PrM is important for tick-borne encephalitis (TBE) virus. Mutation of the 
cleavage site resulted in immature, non-infectious TBE virions in BHK-21 cells. Moreover, co-
expression of the human furin enhanced the accumulation of active human transforming 
growth factor beta (TGF-β) in N. benthamiana.  The researchers also observed proper 
processing of extracted LAP- TGF-β and concluded that plants are a suitable platform for 
producing complex proteins that require accurate post-translational processing to be 
biologically active (Wilbers et al. 2016). 
Plant morphology after infiltration plays an important role in protein expression and 
accumulation. Infection-like symptoms were observed in plants for the replicating vector pRIC 
4.0 and more so for the positive control, pEAQ-N-His (RVFV). Previous studies have shown 
that Rep can induce a hypersensitive response (HR) in N. benthamiana. The HR is associated 
with local necrosis and production of hydrogen peroxide (Van Wezel et al. 2002). However, 
the symptoms observed in this study were not as severe as reported in previous studies. This 
reduction in necrosis may be due to the addition of the TAV 2b silencing suppressor gene on 
the pRIC 4.0 vector. Silencing suppressors have been reported to prolong expression of the 
transgene and reduce infection like symptoms (Takeda et al. 2002).  
Determining an optimal extraction protocol is an important step to obtaining the desired 
protein. Different extraction buffers were used to determine whether changing buffer 
conditions would result in PrME extraction. The extraction buffers were unsuccessful in 
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extracting any of the desired protein, since no ZIKV PrME-His proteins were detected on an 
immunoblot. This may be due to the lack of protein translation taking place for PrME-HIS in 
the plant cell, since the positive control was detected using the same buffers.  
Since no ZIKV PrME was detected other alternatives need to be considered to express the 
protein in plants. The flavivirus E protein contains neutralizing epitopes located within the 
domain III. These peptides are considered important for vaccine development. Studies also 
show that these epitopes are less cross reactive compared to domain I and II of the E protein 
(Beltramello et al. 2010; Chavez et al. 2010). Expression of the PrM with the E protein assists 
with obtaining the genetically correct conformation of E (Konishi & Mason 1993). Yang et al., 
(2017a) recently transiently expressed the ZIKV E protein in N. benthamiana which was highly 
immunogenic in mice. The ZIKV E coding sequence with His tags was cloned into a TMV-based 
expression vector and the researchers were able to achieve substantial protein yields and >90 
% purity. They were also able to show that the E protein was correctly folded since it was 
recognised by a range of mAb that bind to various epitopes of the E protein (Yang, Sun, et al. 
2017). This research confirms that the ZIKV E can be expressed on its own and should be 
considered for eliciting neutralizing antibodies.  
In conclusion, I successfully cloned the ZIKV-PrME-His into two plant expression vectors pRIC 
4-PrME-His and pEAQ-PrME-His which was confirmed by sequencing. However, I was unable 
to achieve PrME-His expression in N. benthamiana. I would assume that either its 
transcription or translation within the plant cell that is not taking place. Further studies will 
need to be carried out to determine whether mRNA is made and to obtain PrME-His 









Chapter 5: General conclusion 
The level of recombinant protein expression and yield is particularly important for commercial 
vaccine production. However, low protein yields and structural heterogeneity have hindered 
plant-based vaccine production. Thus, different strategies have been developed to increase 
protein yields in plants. Plant viruses have been used to introduce foreign genes into plants 
since the early 1980s. Virus-based vectors are useful because of their rapid replication and 
because they can be optimised for high protein expression or use in different plant host 
species. In this study we focused on improving our current expression vectors by examining 
silencing suppressor activity and the application of replication elements taken from different 
viruses.  
RNA silencing is a major antiviral plant defence mechanism that targets the viral genome for 
degradation. Plant viruses use RNA silencing suppressor proteins to counter the plant host 
antiviral response by inhibiting various aspects of the silencing pathway. This prevents viral 
DNA degradation and the inhibition of foreign gene expression. Silencing suppressor genes 
are useful to increase expression of recombinant genes in plant. In this study we explored the 
use of different silencing suppressor proteins to determine which one would best improve 
protein expression. TAV 2b had the greatest impact on recombinant protein expression 
compared to other more commonly used proteins (P19 and NSs). Since the TAV 2b gene is 
much smaller than p19, it will reduce the vector size and increase the efficiency of the 
expression vectors. Further studies that investigate mRNA levels should be carried out using 
reverse transcriptase PCR (RT-qPCR) and compared to other constructs containing silencing 
suppressors. 
Furthermore, one of the main aims of this project was designing and creating replicating plant 
expression vectors using the replication elements from BeYDV, BFDV and alphasatellites. The 
GB cloning technique was used for the first time to ease the cloning process. We were able to 
deconstruct and re-assemble our in-house replicating vectors pRIC 3.0 and pRIC 4.0 and 
confirm that the technique was efficient and useful. However, the same was not achieved 
when trying to assemble the BFDV and alphasatellite expression vectors. Although 
domestication and the multipart assembly of all the DNA parts were confirmed, the final 
assembly was not successful. More time and research are needed to troubleshoot this 
problem. An alternative would be to use a different destination plasmid such as the 
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commonly used plasmids, pRIC 4 or pEAQ-HT. Once all the parts are in the same vector, one 
could digest with the appropriate RE and clone it into the common expression vectors. 
Although, this would take longer and defeat purpose of the whole GB efficient technique, due 
to designing primers and finding the appropriate RE, it would help with generating the new 
vectors in due time. Overall the aim is to design the replicating expression vectors and 
interchange the rep genes between the vectors to improve protein expression in plants. 
Finally, the expression efficiency in N. benthamiana of the above-mentioned vector, 
incorporating the TAV 2b gene and BeYDV replication elements, was tested with ZIKV PrME-
HIS protein. The PrME-HIS was first cloned into the plant expression vectors, pRIC 4.0 and 
pEAQ-HT to see if there was any expression of the protein in plants. Unfortunately, no 
expression was achieved despite optimising different protein extraction buffers, day of 
harvest post infiltration and Agrobacterium infiltration density. Experiments that we could 
consider include targeting the ZIKV PrME proteins to the ER which has been shown to improve 
protein yields, allowing for glycosylation if need be and preventing proteolytic degradation. 
In addition, co-expression with a furin protease could enhance accumulation and aid proper 
processing of the proteins. Expression of the ZIKV E protein alone should also be considered 
as it contains less cross-reactive epitopes 
In conclusion, I was able to determine that the TAV 2b silencing suppressor protein was better 
at improving EGFP expression. The GB technique was shown to ease the difficult cloning 
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pRIC 3.0 (no EGFP) 9881 LIR p35SS - pA35SS SIR rep/repA LIR - - - 
pRIC 3.0 EGFP 9699 LIR p35SS egfp pA35SS SIR rep/repA LIR - - - 
pRIC 4.0 EGFP 8048 LIR p35SS egfp pA35SS SIR rep/repA LIR p35S TAV 2b pA35S 
pPEAQ-HT EGFP (TAV 2b) 11404 - p35S (CPMV 5ʹ UTR) egfp (CPMV 5ʹ UTR) NosT - - - p35S TAV 2b pA35S 
pPEAQ-HT EGFP (NSs) 11560 - p35S (CPMV 5ʹ UTR) egfp (CPMV 5ʹ UTR) NosT - - - p35S NSs pA35S 
pPEAQ-HT EGFP (α-sat rep) 11101 - p35S (CPMV 5ʹ UTR) egfp (CPMV 5ʹ UTR) NosT - - - p35S α-sat rep pA35S 
pPEAQ-HT EGFP (P19) 10675 - p35S (CPMV 5ʹ UTR) egfp (CPMV 5ʹ UTR) NosT - - - p35S P19 pA35S 
pPEAQ-HT EGFP (no P19) 8755 - p35S (CPMV 5ʹ UTR) egfp (CPMV 5ʹ UTR) NosT - - - - - - 
Figure 1: Table presenting pRIC 3.0 and pEAQ-HT constructs with the different silencing suppressor gene. The major features are labelled, and total size indicated. CaMV, cauliflower mosaic 
virus 35S promoter and terminator; Nos, nopaline synthase terminator (blue); CpMV UTR (blue), silencing inhibitor (red), BeYDV replication elements (yellow) and egfp (green). 
